CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: cefaloridine
Accession: CHEBI:3537
browse the term
Definition: A cephalosporin compound having pyridinium-1-ylmethyl and 2-thienylacetamido side-groups. A first-generation semisynthetic derivative of cephalosporin C.
Synonyms: exact_synonym: 3-(pyridinium-1-ylmethyl)-7beta-[(2-thienylacetyl)amino]-3,4-didehydrocepham-4-carboxylate
related_synonym: (6R,7R)-8-oxo-3-(pyridinium-1-ylmethyl)-7-[(2-thienylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate; 7-((2-Thienyl)acetamido)-3-(1-pyridylmethyl)cephalosporanic acid; Cefaloridin; Cefalorizin; Ceflorin; Cepaloridin; Cepalorin; Cephaloridin; Cephaloridine; Cephaloridinum; Formula=C19H17N3O4S2; InChI=1S/C19H17N3O4S2/c23-14(9-13-5-4-8-27-13)20-15-17(24)22-16(19(25)26)12(11-28-18(15)22)10-21-6-2-1-3-7-21/h1-8,15,18H,9-11H2,(H-,20,23,25,26)/t15-,18-/m1/s1; InChIKey=CZTQZXZIADLWOZ-CRAIPNDOSA-N; N-(7-((2-Thienyl)acetamido)ceph-3-em-3-ylmethyl)pyridinium-4-carboxylate; N-(7-(2'-Thienylacetamidoceph-3-ylmethyl))-pyridinium-2-carboxylate; SMILES=[C@]12(N(C(=C(CS1)C[N+]3=CC=CC=C3)C(=O)[O-])C([C@H]2NC(=O)CC=4SC=CC4)=O)[H]; cefaloridina; cefaloridinum
alt_id: CHEBI:235235
xref: CAS:50-59-9; Drug_Central:573; KEGG:C11754; KEGG:D01075
xref_mesh: MESH:D002509
xref: PMID:12569987; PMID:14226120; PMID:2083978; PMID:29017833; PMID:4868829; PMID:5325246; PMID:5740219; PMID:724127; Reaxys:4166301; Wikipedia:Cephaloridine
G
Aadac
arylacetamide deacetylase
increases expression
EXP
Cephaloridine results in increased expression of AADAC mRNA
CTD
PMID:18500788
NCBI chr 2:144,163,436...144,186,086
Ensembl chr 2:144,135,319...144,174,734
G
Aass
aminoadipate-semialdehyde synthase
decreases expression
EXP
Cephaloridine results in decreased expression of AASS mRNA
CTD
PMID:18500788
NCBI chr 4:51,606,461...51,663,136
Ensembl chr 4:51,606,462...51,663,136
G
Abcb1b
ATP-binding cassette, sub-family B member 1B
increases expression
EXP
Cephaloridine results in increased expression of ABCB1B mRNA
CTD
PMID:18500788
NCBI chr 4:25,242,761...25,325,194
Ensembl chr 4:25,242,798...25,325,199
G
Abcc2
ATP binding cassette subfamily C member 2
increases expression
EXP
Cephaloridine results in increased expression of ABCC2 mRNA
CTD
PMID:18500788
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
G
Acmsd
aminocarboxymuconate semialdehyde decarboxylase
decreases expression
EXP
Cephaloridine results in decreased expression of ACMSD mRNA
CTD
PMID:18500788
NCBI chr13:39,200,412...39,245,954
Ensembl chr13:39,200,314...39,245,209
G
Acot9
acyl-CoA thioesterase 9
increases expression
EXP
Cephaloridine results in increased expression of ACOT9 mRNA
CTD
PMID:18500788
NCBI chr X:40,073,197...40,123,573
Ensembl chr X:40,064,810...40,123,559
G
Acsm5
acyl-CoA synthetase medium-chain family member 5
decreases expression
EXP
Cephaloridine results in decreased expression of ACSM5 mRNA
CTD
PMID:18500788
NCBI chr 1:173,870,873...173,896,838
Ensembl chr 1:173,863,041...173,898,588
G
Adam8
ADAM metallopeptidase domain 8
decreases expression
EXP
Cephaloridine results in decreased expression of ADAM8 mRNA
CTD
PMID:18500788
NCBI chr 1:194,776,559...194,789,330
Ensembl chr 1:194,770,060...194,788,801
G
Adgre1
adhesion G protein-coupled receptor E1
increases expression
EXP
Cephaloridine results in increased expression of ADGRE1 mRNA
CTD
PMID:18500788
NCBI chr 9:2,242,476...2,398,000
Ensembl chr 9:2,242,474...2,398,000
G
Adora2a
adenosine A2a receptor
increases expression
EXP
Cephaloridine results in increased expression of ADORA2A mRNA
CTD
PMID:18500788
NCBI chr20:13,315,848...13,333,386
Ensembl chr20:13,315,853...13,333,386
G
Adra1d
adrenoceptor alpha 1D
increases expression
EXP
Cephaloridine results in increased expression of ADRA1D mRNA
CTD
PMID:18500788
NCBI chr 3:118,793,356...118,809,354
Ensembl chr 3:118,793,346...118,809,354
G
Aftph
aftiphilin
decreases expression
EXP
Cephaloridine results in decreased expression of AFTPH mRNA
CTD
PMID:18500788
NCBI chr14:94,871,429...94,925,625
Ensembl chr14:94,871,429...94,925,376
G
Akr1b1
aldo-keto reductase family 1 member B1
increases expression
EXP
Cephaloridine results in increased expression of AKR1B1 mRNA
CTD
PMID:18172885
NCBI chr 4:62,932,033...62,946,126
Ensembl chr 4:62,932,031...62,946,157
G
Akr1d1
aldo-keto reductase family 1, member D1
increases expression
EXP
Cephaloridine results in increased expression of AKR1D1 mRNA
CTD
PMID:18172885
NCBI chr 4:66,154,246...66,187,505
Ensembl chr 4:66,154,248...66,186,372
G
Alas1
5'-aminolevulinate synthase 1
increases expression
EXP
Cephaloridine results in increased expression of ALAS1 mRNA
CTD
PMID:18500788
NCBI chr 8:106,876,514...106,889,917
Ensembl chr 8:106,876,514...106,889,917
G
Aldh3a1
aldehyde dehydrogenase 3 family, member A1
increases expression
EXP
Cephaloridine results in increased expression of ALDH3A1 mRNA
CTD
PMID:18500788
NCBI chr10:45,892,993...45,902,680
Ensembl chr10:45,892,924...45,902,681
G
Aldh3b1
aldehyde dehydrogenase 3 family, member B1
increases expression
EXP
Cephaloridine results in increased expression of ALDH3B1 mRNA
CTD
PMID:18500788
NCBI chr 1:201,145,309...201,162,675
Ensembl chr 1:201,145,309...201,163,921
G
Aldoa
aldolase, fructose-bisphosphate A
affects expression
EXP
Cephaloridine affects the expression of ALDOA mRNA
CTD
PMID:18172885
NCBI chr 1:181,402,275...181,407,476
Ensembl chr 1:181,402,275...181,406,182
G
Amer2
APC membrane recruitment protein 2
decreases expression
EXP
Cephaloridine results in decreased expression of AMER2 mRNA
CTD
PMID:18500788
NCBI chr15:34,525,352...34,535,660
Ensembl chr15:34,524,542...34,528,455
G
Amigo2
adhesion molecule with Ig like domain 2
increases expression
EXP
Cephaloridine results in increased expression of AMIGO2 mRNA
CTD
PMID:18500788
NCBI chr 7:128,391,493...128,394,589
Ensembl chr 7:128,390,412...128,394,695
G
Ampd1
adenosine monophosphate deaminase 1
increases expression
EXP
Cephaloridine results in increased expression of AMPD1 mRNA
CTD
PMID:18500788
NCBI chr 2:190,598,707...190,619,938
Ensembl chr 2:190,598,700...190,619,938
G
Ampd3
adenosine monophosphate deaminase 3
increases expression
EXP
Cephaloridine results in increased expression of AMPD3 mRNA
CTD
PMID:18500788
NCBI chr 1:164,884,823...164,929,899
Ensembl chr 1:164,885,320...164,929,887
G
Angptl4
angiopoietin-like 4
increases expression
EXP
Cephaloridine results in increased expression of ANGPTL4 mRNA
CTD
PMID:18500788
NCBI chr 7:14,550,288...14,557,797
Ensembl chr 7:14,550,311...14,556,519
G
Anln
anillin, actin binding protein
decreases expression
EXP
Cephaloridine results in decreased expression of ANLN mRNA
CTD
PMID:18500788
NCBI chr 8:20,858,227...20,921,602
Ensembl chr 8:20,858,228...20,921,538
G
Anxa13
annexin A13
decreases expression
EXP
Cephaloridine results in decreased expression of ANXA13 mRNA
CTD
PMID:18500788
NCBI chr 7:89,884,356...89,936,907
Ensembl chr 7:89,884,356...89,936,907
G
Anxa7
annexin A7
increases expression
EXP
Cephaloridine results in increased expression of ANXA7 mRNA
CTD
PMID:18500788
NCBI chr15:3,821,798...3,849,659
Ensembl chr15:3,821,845...3,849,385
G
Apcs
amyloid P component, serum
decreases expression
EXP
Cephaloridine results in decreased expression of APCS mRNA
CTD
PMID:18500788
NCBI chr13:85,373,219...85,374,195
Ensembl chr13:85,373,220...85,374,298
G
Apoa4
apolipoprotein A4
increases expression
EXP
Cephaloridine results in increased expression of APOA4 mRNA
CTD
PMID:18500788
NCBI chr 8:46,539,083...46,541,464
Ensembl chr 8:46,539,082...46,541,469
G
Apob
apolipoprotein B
increases expression
EXP
Cephaloridine results in increased expression of APOB mRNA
CTD
PMID:18500788
NCBI chr 6:30,844,386...30,883,983
Ensembl chr 6:30,844,368...30,892,497
G
Apoc2
apolipoprotein C2
increases expression
EXP
Cephaloridine results in increased expression of APOC2 mRNA
CTD
PMID:18500788
NCBI chr 1:79,329,429...79,334,397
Ensembl chr 1:79,329,428...79,334,476
G
Apold1
apolipoprotein L domain containing 1
decreases expression
EXP
Cephaloridine results in decreased expression of APOLD1 mRNA
CTD
PMID:18500788
NCBI chr 4:167,768,437...167,825,706
Ensembl chr 4:167,818,271...167,825,706
G
Arfgef3
ARFGEF family member 3
decreases expression
EXP
Cephaloridine results in decreased expression of ARFGEF3 mRNA
CTD
PMID:18500788
NCBI chr 1:13,245,578...13,404,319
Ensembl chr 1:13,244,830...13,404,084
G
Arhgap35
Rho GTPase activating protein 35
decreases expression
EXP
Cephaloridine results in decreased expression of ARHGAP35 mRNA
CTD
PMID:18500788
NCBI chr 1:77,202,436...77,319,298
Ensembl chr 1:77,202,436...77,319,298
G
Arid5a
AT-rich interaction domain 5A
increases expression
EXP
Cephaloridine results in increased expression of ARID5A mRNA
CTD
PMID:18500788
NCBI chr 9:38,534,612...38,549,467
Ensembl chr 9:38,534,590...38,547,597
G
Asf1b
anti-silencing function 1B histone chaperone
increases expression
EXP
Cephaloridine results in increased expression of ASF1B mRNA
CTD
PMID:18500788
NCBI chr19:24,181,024...24,195,604
Ensembl chr19:24,181,028...24,195,549
G
Ash1l
ASH1 like histone lysine methyltransferase
decreases expression
EXP
Cephaloridine results in decreased expression of ASH1L mRNA
CTD
PMID:18500788
NCBI chr 2:174,346,267...174,483,057
Ensembl chr 2:174,346,150...174,483,055
G
Asns
asparagine synthetase (glutamine-hydrolyzing)
increases expression
EXP
Cephaloridine results in increased expression of ASNS mRNA
CTD
PMID:18500788
NCBI chr 4:35,784,995...35,803,474
Ensembl chr 4:35,785,237...35,803,423
G
Atad1
ATPase family, AAA domain containing 1
increases expression
EXP
Cephaloridine results in increased expression of ATAD1 mRNA
CTD
PMID:18500788
NCBI chr 1:230,544,227...230,610,524
Ensembl chr 1:230,544,047...230,596,548
G
Atad2
ATPase family, AAA domain containing 2
increases expression
EXP
Cephaloridine results in increased expression of ATAD2 mRNA
CTD
PMID:18500788
NCBI chr 7:89,634,123...89,676,738
Ensembl chr 7:89,634,123...89,676,738
G
Atf3
activating transcription factor 3
decreases expression
EXP
Cephaloridine results in decreased expression of ATF3 mRNA
CTD
PMID:18500788
NCBI chr13:102,751,278...102,800,520
Ensembl chr13:102,751,321...102,764,631
G
Atl1
atlastin GTPase 1
increases expression
EXP
Cephaloridine results in increased expression of ATL1 mRNA
CTD
PMID:18500788
NCBI chr 6:88,377,168...88,475,242
Ensembl chr 6:88,377,239...88,475,204
G
Atp11c
ATPase phospholipid transporting 11C
decreases expression
EXP
Cephaloridine results in decreased expression of ATP11C mRNA
CTD
PMID:18500788
NCBI chr X:138,564,459...138,752,116
Ensembl chr X:138,565,836...138,751,204
G
Atp12a
ATPase H+/K+ transporting non-gastric alpha2 subunit
increases expression
EXP
Cephaloridine results in increased expression of ATP12A mRNA
CTD
PMID:18500788
NCBI chr15:30,443,571...30,468,229
Ensembl chr15:30,443,571...30,468,229
G
Aurkb
aurora kinase B
decreases expression
EXP
Cephaloridine results in decreased expression of AURKB mRNA
CTD
PMID:18500788
NCBI chr10:53,744,290...53,750,831
Ensembl chr10:53,745,142...53,750,837
G
B3galt2
Beta-1,3-galactosyltransferase 2
decreases expression
EXP
Cephaloridine results in decreased expression of B3GALT2 mRNA
CTD
PMID:18500788
NCBI chr13:55,389,406...55,398,419
Ensembl chr13:55,389,406...55,398,419
G
B3gnt7
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7
decreases expression
EXP
Cephaloridine results in decreased expression of B3GNT7 mRNA
CTD
PMID:18500788
NCBI chr 9:86,956,220...86,960,171
Ensembl chr 9:86,956,220...86,960,170
G
Bag3
BAG cochaperone 3
increases expression
EXP
Cephaloridine results in increased expression of BAG3 mRNA
CTD
PMID:18500788
NCBI chr 1:183,103,038...183,126,862
Ensembl chr 1:183,102,871...183,126,858
G
Bak1
BCL2-antagonist/killer 1
increases expression
EXP
Cephaloridine results in increased expression of BAK1 mRNA
CTD
PMID:18500788
NCBI chr20:5,100,480...5,109,669
Ensembl chr20:5,100,480...5,109,264
G
Bard1
BRCA1 associated RING domain 1
increases expression
EXP
Cephaloridine results in increased expression of BARD1 mRNA
CTD
PMID:18500788
NCBI chr 9:72,616,070...72,694,553
Ensembl chr 9:72,623,155...72,694,265
G
Batf
basic leucine zipper ATF-like transcription factor
increases expression
EXP
Cephaloridine results in increased expression of BATF mRNA
CTD
PMID:18500788
NCBI chr 6:105,353,715...105,376,051
Ensembl chr 6:105,353,715...105,376,051
G
Bcl2l1
Bcl2-like 1
affects expression
EXP
Cephaloridine affects the expression of BCL2L1 mRNA
CTD
PMID:18172885
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479 Ensembl chr 1:141,253,523...141,303,479
G
Bex2
brain expressed X-linked 2
increases expression
EXP
Cephaloridine results in increased expression of BEX1 mRNA
CTD
PMID:18500788
NCBI chr X:99,019,847...99,021,375
Ensembl chr X:99,019,000...99,021,503
G
Bex4
brain expressed, X-linked 4
increases expression
EXP
Cephaloridine results in increased expression of BEX4 mRNA
CTD
PMID:18500788
NCBI chr X:99,131,985...99,133,417
Ensembl chr X:99,131,942...99,133,531
G
Bhlhe41
basic helix-loop-helix family, member e41
increases expression
EXP
Cephaloridine results in increased expression of BHLHE41 mRNA
CTD
PMID:18500788
NCBI chr 4:178,834,264...178,838,618
Ensembl chr 4:178,834,271...178,838,468
G
Birc3
baculoviral IAP repeat-containing 3
increases expression
EXP
Cephaloridine results in increased expression of BIRC3 mRNA
CTD
PMID:18500788
NCBI chr 8:5,000,844...5,028,470
Ensembl chr 8:5,000,845...5,015,802
G
Blvrb
biliverdin reductase B
increases expression
EXP
Cephaloridine results in increased expression of BLVRB mRNA
CTD
PMID:18500788
NCBI chr 1:82,738,646...82,756,312
Ensembl chr 1:82,738,695...82,770,375
G
Bpi
bactericidal/permeability-increasing protein
increases expression
EXP
Cephaloridine results in increased expression of BPI mRNA
CTD
PMID:18500788
NCBI chr 3:146,909,626...146,936,487
Ensembl chr 3:146,909,629...146,936,221
G
Brip1
BRCA1 interacting DNA helicase 1
increases expression
EXP
Cephaloridine results in increased expression of BRIP1 mRNA
CTD
PMID:18500788
NCBI chr10:70,907,266...71,031,502
Ensembl chr10:70,907,371...71,030,324
G
Bsnd
barttin CLCNK type accessory subunit beta
increases expression
EXP
Cephaloridine results in increased expression of BSND mRNA
CTD
PMID:18500788
NCBI chr 5:121,251,774...121,260,571
Ensembl chr 5:121,251,774...121,260,571
G
Btg2
BTG anti-proliferation factor 2
decreases expression
EXP
Cephaloridine results in decreased expression of BTG2 mRNA
CTD
PMID:18500788
NCBI chr13:45,531,881...45,535,642
Ensembl chr13:45,531,925...45,535,628
G
Bub1b
BUB1 mitotic checkpoint serine/threonine kinase B
decreases expression
EXP
Cephaloridine results in decreased expression of BUB1B mRNA
CTD
PMID:18500788
NCBI chr 3:105,563,089...105,615,547
Ensembl chr 3:105,563,138...105,615,547
G
C10h16orf89
similar to human chromosome 16 open reading frame 89
increases expression
EXP
Cephaloridine results in increased expression of C10H16ORF89 mRNA
CTD
PMID:18500788
NCBI chr10:10,361,909...10,371,046
Ensembl chr10:10,361,948...10,371,046
G
C1qtnf1
C1q and TNF related 1
increases expression
EXP
Cephaloridine results in increased expression of C1QTNF1 mRNA
CTD
PMID:18500788
NCBI chr10:103,660,319...103,681,662
Ensembl chr10:103,660,327...103,681,660
G
C5
complement C5
decreases expression
EXP
Cephaloridine results in decreased expression of C5 mRNA
CTD
PMID:18500788
NCBI chr 3:18,270,696...18,361,994
Ensembl chr 3:18,270,696...18,361,994
G
C6
complement C6
increases expression
EXP
Cephaloridine results in increased expression of C6 mRNA
CTD
PMID:18500788
NCBI chr 2:53,846,028...53,921,279
Ensembl chr 2:53,851,985...53,921,275
G
Cacna1h
calcium voltage-gated channel subunit alpha1 H
increases expression
EXP
Cephaloridine results in increased expression of CACNA1H mRNA
CTD
PMID:18500788
NCBI chr10:14,390,104...14,448,204
Ensembl chr10:14,390,113...14,448,376
G
Cacng3
calcium voltage-gated channel auxiliary subunit gamma 3
increases expression
EXP
Cephaloridine results in increased expression of CACNG3 mRNA
CTD
PMID:18500788
NCBI chr 1:177,201,361...177,297,019
Ensembl chr 1:177,201,288...177,297,024
G
Calb1
calbindin 1
increases expression
EXP
Cephaloridine results in increased expression of CALB1 mRNA
CTD
PMID:18500788
NCBI chr 5:29,375,624...29,402,532
Ensembl chr 5:29,375,642...29,402,431
G
Calb2
calbindin 2
decreases expression
EXP
Cephaloridine results in decreased expression of CALB2 mRNA
CTD
PMID:18500788
NCBI chr19:38,114,435...38,141,438
Ensembl chr19:38,114,424...38,141,438
G
Calr
calreticulin
increases expression
EXP
Cephaloridine results in increased expression of CALR mRNA
CTD
PMID:18172885
NCBI chr19:23,308,525...23,313,420
Ensembl chr19:23,308,351...23,313,414
G
Camkv
CaM kinase-like vesicle-associated
increases expression
EXP
Cephaloridine results in increased expression of CAMKV mRNA
CTD
PMID:18500788
NCBI chr 8:108,626,821...108,641,169
Ensembl chr 8:108,626,821...108,641,169
G
Canx
calnexin
increases expression
EXP
Cephaloridine results in increased expression of CANX mRNA
CTD
PMID:18172885
NCBI chr10:34,623,865...34,656,866
Ensembl chr10:34,625,191...34,656,821
G
Cat
catalase
affects expression
EXP
Cephaloridine affects the expression of CAT protein
CTD
PMID:9933756
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Ccl17
C-C motif chemokine ligand 17
increases expression
EXP
Cephaloridine results in increased expression of CCL17 mRNA
CTD
PMID:18500788
NCBI chr19:10,202,128...10,203,903
Ensembl chr19:10,202,128...10,203,819
G
Ccl19
C-C motif chemokine ligand 19
increases expression
EXP
Cephaloridine results in increased expression of CCL19 mRNA
CTD
PMID:18500788
NCBI chr 5:56,963,364...56,965,308
Ensembl chr 5:56,963,364...56,965,308
G
Ccl20
C-C motif chemokine ligand 20
increases expression
EXP
Cephaloridine results in increased expression of CCL20 mRNA
CTD
PMID:18500788
NCBI chr 9:84,389,031...84,391,629
Ensembl chr 9:84,388,904...84,391,629
G
Ccl28
C-C motif chemokine ligand 28
increases expression
EXP
Cephaloridine results in increased expression of CCL28 mRNA
CTD
PMID:18500788
NCBI chr 2:51,601,354...51,625,999
Ensembl chr 2:51,601,331...51,625,997
G
Ccl3
C-C motif chemokine ligand 3
decreases expression
EXP
Cephaloridine results in decreased expression of CCL3 mRNA
CTD
PMID:18500788
NCBI chr10:68,451,388...68,452,938
Ensembl chr10:68,451,388...68,452,938
G
Ccl4
C-C motif chemokine ligand 4
decreases expression
EXP
Cephaloridine results in decreased expression of CCL4 mRNA
CTD
PMID:18500788
NCBI chr10:68,466,394...68,468,229
Ensembl chr10:68,452,052...68,468,231
G
Ccn2
cellular communication network factor 2
decreases expression
EXP
Cephaloridine results in decreased expression of CCN2 mRNA
CTD
PMID:18500788
NCBI chr 1:20,802,199...20,805,315
Ensembl chr 1:20,802,199...20,805,734
G
Ccna2
cyclin A2
decreases expression
EXP
Cephaloridine results in decreased expression of CCNA2 mRNA
CTD
PMID:18500788
NCBI chr 2:119,427,239...119,433,645
Ensembl chr 2:119,426,089...119,433,577
G
Ccnb1
cyclin B1
decreases expression
EXP
Cephaloridine results in decreased expression of CCNB1 mRNA
CTD
PMID:18500788
NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172
G
Ccnb2
cyclin B2
decreases expression
EXP
Cephaloridine results in decreased expression of CCNB2 mRNA
CTD
PMID:18500788
NCBI chr 8:71,087,594...71,100,794
Ensembl chr 8:71,087,595...71,100,874
G
Ccne1
cyclin E1
increases expression
EXP
Cephaloridine results in increased expression of CCNE1 mRNA
CTD
PMID:18500788
NCBI chr 1:90,781,947...90,791,188
Ensembl chr 1:90,781,949...90,791,101
G
Ccne2
cyclin E2
increases expression
EXP
Cephaloridine results in increased expression of CCNE2 mRNA
CTD
PMID:18500788
NCBI chr 5:24,285,078...24,298,258
Ensembl chr 5:24,284,922...24,297,632
G
Cd52
CD52 molecule
decreases expression
EXP
Cephaloridine results in decreased expression of CD52 mRNA
CTD
PMID:18500788
NCBI chr 5:146,319,789...146,321,348
Ensembl chr 5:146,319,969...146,321,348
G
Cd72
Cd72 molecule
increases expression
EXP
Cephaloridine results in increased expression of CD72 mRNA
CTD
PMID:18500788
NCBI chr 5:57,697,361...57,704,980
Ensembl chr 5:57,697,367...57,704,725
G
Cd86
CD86 molecule
increases expression
EXP
Cephaloridine results in increased expression of CD86 mRNA
CTD
PMID:18500788
NCBI chr11:64,142,193...64,200,816
Ensembl chr11:64,163,828...64,200,818
G
Cdc42
cell division cycle 42
decreases expression
EXP
Cephaloridine results in decreased expression of CDC42 mRNA
CTD
PMID:18172885
NCBI chr 5:149,555,069...149,593,239
Ensembl chr 5:149,553,724...149,593,111
G
Cdc45
cell division cycle 45
increases expression
EXP
Cephaloridine results in increased expression of CDC45 mRNA
CTD
PMID:18500788
NCBI chr11:82,185,427...82,210,630
Ensembl chr11:82,185,473...82,210,619
G
Cdc6
cell division cycle 6
increases expression
EXP
Cephaloridine results in increased expression of CDC6 mRNA
CTD
PMID:18500788
NCBI chr10:83,864,189...83,878,011
Ensembl chr10:83,864,638...83,878,011
G
Cdca2
cell division cycle associated 2
decreases expression
EXP
Cephaloridine results in decreased expression of CDCA2 mRNA
CTD
PMID:18500788
NCBI chr15:41,895,946...41,942,226
Ensembl chr15:41,895,901...41,941,611
G
Cdk1
cyclin-dependent kinase 1
decreases expression
EXP
Cephaloridine results in decreased expression of CDK1 mRNA
CTD
PMID:18500788
NCBI chr20:19,266,226...19,281,417
Ensembl chr20:19,266,248...19,281,408
G
Cdkl1
cyclin dependent kinase like 1
decreases expression
EXP
Cephaloridine results in decreased expression of CDKL1 mRNA
CTD
PMID:18500788
NCBI chr 6:88,224,154...88,273,434
Ensembl chr 6:88,224,143...88,270,276
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
decreases expression
EXP
Cephaloridine results in decreased expression of CDKN1A mRNA
CTD
PMID:18500788
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
G
Cdkn1b
cyclin-dependent kinase inhibitor 1B
decreases expression
EXP
Cephaloridine results in decreased expression of CDKN1B mRNA
CTD
PMID:18500788
NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982
G
Cdt1
chromatin licensing and DNA replication factor 1
increases expression
EXP
Cephaloridine results in increased expression of CDT1 mRNA
CTD
PMID:18500788
NCBI chr19:50,620,713...50,625,659
Ensembl chr19:50,620,713...50,625,659
G
Ceacam16
CEA cell adhesion molecule 16, tectorial membrane component
increases expression
EXP
Cephaloridine results in increased expression of CEACAM16 mRNA
CTD
PMID:18500788
NCBI chr 1:79,514,975...79,524,871
Ensembl chr 1:79,514,975...79,524,871
G
Cenpk
centromere protein K
increases expression
EXP
Cephaloridine results in increased expression of CENPK mRNA
CTD
PMID:18500788
NCBI chr 2:35,360,390...35,421,372
Ensembl chr 2:35,360,132...35,385,706
G
Cenpq
centromere protein Q
increases expression
EXP
Cephaloridine results in increased expression of CENPQ mRNA
CTD
PMID:18500788
NCBI chr 9:19,957,122...19,972,807
Ensembl chr 9:19,957,048...19,972,789
G
Cesl1
carboxylesterase-like 1
decreases expression
EXP
Cephaloridine results in decreased expression of CESL1 mRNA
CTD
PMID:18500788
NCBI chr19:22,670,709...23,006,329
Ensembl chr19:22,670,712...22,712,608
G
Cfap263
cilia and flagella associated protein 263
increases expression
EXP
Cephaloridine results in increased expression of CCDC113 mRNA
CTD
PMID:18500788
NCBI chr19:9,497,000...9,516,917
Ensembl chr19:9,496,886...9,516,923
G
Chaf1a
chromatin assembly factor 1 subunit A
increases expression
EXP
Cephaloridine results in increased expression of CHAF1A mRNA
CTD
PMID:18500788
NCBI chr 9:873,953...900,701
Ensembl chr 9:874,051...900,654
G
Chaf1b
chromatin assembly factor 1 subunit B
increases expression
EXP
Cephaloridine results in increased expression of CHAF1B mRNA
CTD
PMID:18500788
NCBI chr11:33,200,894...33,221,076
Ensembl chr11:33,200,981...33,221,070
G
Chd4
chromodomain helicase DNA binding protein 4
decreases expression
EXP
Cephaloridine results in decreased expression of CHD4 mRNA
CTD
PMID:18500788
NCBI chr 4:157,898,503...157,931,632
Ensembl chr 4:157,899,391...157,931,541
G
Chd6
chromodomain helicase DNA binding protein 6
decreases expression
EXP
Cephaloridine results in decreased expression of CHD6 mRNA
CTD
PMID:18500788
NCBI chr 3:149,596,509...149,757,765
Ensembl chr 3:149,596,509...149,757,755
G
Chek1
checkpoint kinase 1
increases expression
EXP
Cephaloridine results in increased expression of CHEK1 mRNA
CTD
PMID:18500788
NCBI chr 8:36,420,565...36,443,477
Ensembl chr 8:36,420,569...36,441,009
G
Chst7
carbohydrate sulfotransferase 7
decreases expression
EXP
Cephaloridine results in decreased expression of CHST7 mRNA
CTD
PMID:18500788
NCBI chr X:2,396,260...2,432,828
Ensembl chr X:2,393,874...2,432,840
G
Chtf18
chromosome transmission fidelity factor 18
increases expression
EXP
Cephaloridine results in increased expression of CHTF18 mRNA
CTD
PMID:18500788
NCBI chr10:14,743,006...14,751,044
Ensembl chr10:14,742,621...14,751,050
G
Cilp
cartilage intermediate layer protein
decreases expression
EXP
Cephaloridine results in decreased expression of CILP mRNA
CTD
PMID:18500788
NCBI chr 8:65,777,281...65,792,251
Ensembl chr 8:65,777,281...65,792,251
G
Cited2
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2
increases expression
EXP
Cephaloridine results in increased expression of CITED2 mRNA
CTD
PMID:18172885
NCBI chr 1:12,312,426...12,314,869
Ensembl chr 1:12,312,160...12,314,897
G
Ckap2
cytoskeleton associated protein 2
decreases expression
EXP
Cephaloridine results in decreased expression of CKAP2 mRNA
CTD
PMID:18500788
NCBI chr16:69,839,668...69,864,852
Ensembl chr16:69,839,630...69,864,913
G
Cldn14
claudin 14
increases expression
EXP
Cephaloridine results in increased expression of CLDN14 mRNA
CTD
PMID:18500788
NCBI chr11:33,232,281...33,329,440
Ensembl chr11:33,232,220...33,329,171
G
Clstn2
calsyntenin 2
decreases expression
EXP
Cephaloridine results in decreased expression of CLSTN2 mRNA
CTD
PMID:18500788
NCBI chr 8:98,020,406...98,637,232
Ensembl chr 8:98,021,666...98,637,731
G
Cmip
c-Maf-inducing protein
decreases expression
EXP
Cephaloridine results in decreased expression of CMIP mRNA
CTD
PMID:18500788
NCBI chr19:45,304,597...45,510,653
Ensembl chr19:45,304,031...45,508,709
G
Cndp1
carnosine dipeptidase 1
decreases expression
EXP
Cephaloridine results in decreased expression of CNDP1 mRNA
CTD
PMID:18500788
NCBI chr18:77,984,886...78,030,837
Ensembl chr18:77,984,907...78,007,765
G
Col4a4
collagen type IV alpha 4 chain
decreases expression
EXP
Cephaloridine results in decreased expression of COL4A4 mRNA
CTD
PMID:18500788
NCBI chr 9:83,833,173...83,875,436
Ensembl chr 9:83,755,515...83,875,876
G
Col7a1
collagen type VII alpha 1 chain
increases expression
EXP
Cephaloridine results in increased expression of COL7A1 mRNA
CTD
PMID:18500788
NCBI chr 8:109,604,877...109,637,249
Ensembl chr 8:109,604,861...109,637,252
G
Cpt1b
carnitine palmitoyltransferase 1B
increases expression
EXP
Cephaloridine results in increased expression of CPT1B mRNA
CTD
PMID:18500788
NCBI chr 7:120,491,354...120,500,833
Ensembl chr 7:120,491,354...120,500,404
G
Crabp1
cellular retinoic acid binding protein 1
increases expression
EXP
Cephaloridine results in increased expression of CRABP1 mRNA
CTD
PMID:18500788
NCBI chr 8:55,138,363...55,159,360
Ensembl chr 8:55,151,285...55,159,360
G
Crebbp
CREB binding protein
decreases expression
EXP
Cephaloridine results in decreased expression of CREBBP mRNA
CTD
PMID:18500788
NCBI chr10:11,335,551...11,461,888
Ensembl chr10:11,335,953...11,461,888
G
Cry1
cryptochrome circadian regulator 1
increases expression
EXP
Cephaloridine results in increased expression of CRY1 mRNA
CTD
PMID:18500788
NCBI chr 7:18,529,823...18,594,092
Ensembl chr 7:18,529,823...18,594,091
G
Cxcl1
C-X-C motif chemokine ligand 1
decreases expression
EXP
Cephaloridine results in decreased expression of CXCL1 mRNA
CTD
PMID:18500788
NCBI chr14:17,193,364...17,195,143
Ensembl chr14:17,193,365...17,195,215
G
Cxcl10
C-X-C motif chemokine ligand 10
increases expression
EXP
Cephaloridine results in increased expression of CXCL10 mRNA
CTD
PMID:18500788
NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975
G
Cxcl13
C-X-C motif chemokine ligand 13
increases expression
EXP
Cephaloridine results in increased expression of CXCL13 mRNA
CTD
PMID:18500788
NCBI chr14:13,608,894...13,613,965
Ensembl chr14:13,608,902...13,613,933
G
Cxcl14
C-X-C motif chemokine ligand 14
increases expression
EXP
Cephaloridine results in increased expression of CXCL14 mRNA
CTD
PMID:18500788
NCBI chr17:8,317,930...8,325,956
Ensembl chr17:8,317,933...8,324,839
G
Cxxc4
CXXC finger protein 4
decreases expression
EXP
Cephaloridine results in decreased expression of CXXC4 mRNA
CTD
PMID:18500788
NCBI chr 2:222,664,148...222,689,365
Ensembl chr 2:222,664,771...222,689,365
G
Cyb5a
cytochrome b5 type A
increases expression
EXP
Cephaloridine results in increased expression of CYB5A mRNA
CTD
PMID:18172885
NCBI chr18:78,213,067...78,245,677
Ensembl chr18:78,202,342...78,258,535 Ensembl chr18:78,202,342...78,258,535
G
Cyp1b1
cytochrome P450, family 1, subfamily b, polypeptide 1
increases expression
EXP
Cephaloridine results in increased expression of CYP1B1 mRNA
CTD
PMID:18500788
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
G
Cyp24a1
cytochrome P450, family 24, subfamily a, polypeptide 1
decreases expression
EXP
Cephaloridine results in decreased expression of CYP24A1 mRNA
CTD
PMID:18500788
NCBI chr 3:159,275,947...159,290,383
Ensembl chr 3:159,275,947...159,290,383
G
Cyp2c11
cytochrome P450, subfamily 2, polypeptide 11
decreases expression
EXP
Cephaloridine results in decreased expression of CYP2C mRNA
CTD
PMID:18500788
NCBI chr 1:236,762,719...236,799,069
Ensembl chr 1:236,762,842...236,799,066
G
Cyp7b1
cytochrome P450 family 7 subfamily B member 1
increases expression
EXP
Cephaloridine results in increased expression of CYP7B1 mRNA
CTD
PMID:18500788
NCBI chr 2:100,502,791...100,669,713
Ensembl chr 2:100,502,791...100,669,698
G
Dctpp1
dCTP pyrophosphatase 1
increases expression
EXP
Cephaloridine results in increased expression of DCTPP1 mRNA
CTD
PMID:18500788
NCBI chr 1:181,877,440...181,880,833
Ensembl chr 1:181,877,437...181,880,839
G
Dctpp1-ps2
dCTP pyrophosphatase 1, pseudogene 2
increases expression
EXP
Cephaloridine results in increased expression of DCTPP1-PS2 mRNA
CTD
PMID:18500788
NCBI chr16:1,392,967...1,393,868
G
Ddc
dopa decarboxylase
decreases expression
EXP
Cephaloridine results in decreased expression of DDC mRNA
CTD
PMID:18500788
NCBI chr14:86,378,685...86,469,189
Ensembl chr14:86,378,685...86,469,208
G
Ddit4
DNA-damage-inducible transcript 4
decreases expression
EXP
Cephaloridine results in decreased expression of DDIT4 mRNA
CTD
PMID:18500788
NCBI chr20:27,891,989...27,894,088
Ensembl chr20:27,891,998...27,894,105
G
Ddit4l
DNA-damage-inducible transcript 4-like
increases expression
EXP
Cephaloridine results in increased expression of DDIT4L mRNA
CTD
PMID:18500788
NCBI chr 2:226,128,273...226,131,044
Ensembl chr 2:226,128,276...226,131,375
G
Ddx39a
DExD-box helicase 39A
increases expression
EXP
Cephaloridine results in increased expression of DDX39A mRNA
CTD
PMID:18500788
NCBI chr19:24,418,743...24,427,422
Ensembl chr19:24,418,114...24,426,954
G
Ddx6
DEAD-box helicase 6
decreases expression
EXP
Cephaloridine results in decreased expression of DDX6 mRNA
CTD
PMID:18500788
NCBI chr 8:44,931,127...44,967,773
Ensembl chr 8:44,931,974...44,964,405 Ensembl chr 8:44,931,974...44,964,405
G
Decr2
2,4-dienoyl-CoA reductase 2
decreases expression
EXP
Cephaloridine results in decreased expression of DECR2 mRNA
CTD
PMID:18500788
NCBI chr10:15,104,907...15,113,281
Ensembl chr10:15,002,926...15,118,479
G
Dhrs2l1
dehydrogenase/reductase member 2 like 1
increases expression
EXP
Cephaloridine results in increased expression of DHRS2L1 mRNA
CTD
PMID:18500788
NCBI chr15:28,635,197...28,638,087
Ensembl chr15:28,635,197...28,638,087
G
Dlgap1
DLG associated protein 1
increases expression
EXP
Cephaloridine results in increased expression of DLGAP1 mRNA
CTD
PMID:18500788
NCBI chr 9:109,857,500...110,726,817
Ensembl chr 9:110,167,448...110,726,817
G
Dnah7
dynein, axonemal, heavy chain 7
decreases expression
EXP
Cephaloridine results in decreased expression of DNAH7 mRNA
CTD
PMID:18500788
NCBI chr 9:54,960,235...55,266,529
Ensembl chr 9:54,960,440...55,262,297
G
Dnah9
dynein, axonemal, heavy chain 9
decreases expression
EXP
Cephaloridine results in decreased expression of DNAH9 mRNA
CTD
PMID:18500788
NCBI chr10:50,496,174...50,864,909
Ensembl chr10:50,497,688...50,864,949
G
Dnase1l3
deoxyribonuclease 1L3
increases expression
EXP
Cephaloridine results in increased expression of DNASE1L3 mRNA
CTD
PMID:18500788
NCBI chr15:16,922,335...16,948,322
Ensembl chr15:16,922,335...16,948,317
G
Dnph1
2'-deoxynucleoside 5'-phosphate N-hydrolase 1
increases expression
EXP
Cephaloridine results in increased expression of DNPH1 mRNA
CTD
PMID:18500788
NCBI chr 9:14,481,296...14,484,034
Ensembl chr 9:14,481,066...14,484,022
G
Donson
DNA replication fork stabilization factor DONSON
increases expression
EXP
Cephaloridine results in increased expression of DONSON mRNA
CTD
PMID:18500788
NCBI chr11:30,919,834...30,933,150
Ensembl chr11:30,923,239...30,932,889
G
Dpf1
double PHD fingers 1
increases expression
EXP
Cephaloridine results in increased expression of DPF1 mRNA
CTD
PMID:18500788
NCBI chr 1:84,602,212...84,615,954
Ensembl chr 1:84,602,336...84,615,950
G
Dscc1
DNA replication and sister chromatid cohesion 1
increases expression
EXP
Cephaloridine results in increased expression of DSCC1 mRNA
CTD
PMID:18500788
NCBI chr 7:86,482,588...86,498,212
Ensembl chr 7:86,482,588...86,498,212
G
Dsg2
desmoglein 2
increases expression
EXP
Cephaloridine results in increased expression of DSG2 mRNA
CTD
PMID:18500788
NCBI chr18:11,846,207...11,904,630
Ensembl chr18:11,846,183...11,904,156
G
Dtx4
deltex E3 ubiquitin ligase 4
increases expression
EXP
Cephaloridine results in increased expression of DTX4 mRNA
CTD
PMID:18500788
NCBI chr 1:209,457,719...209,545,163
Ensembl chr 1:209,460,735...209,492,818
G
Dusp6
dual specificity phosphatase 6
affects expression
EXP
Cephaloridine affects the expression of DUSP6 mRNA
CTD
PMID:18172885
NCBI chr 7:34,092,848...34,097,186
Ensembl chr 7:34,092,943...34,097,185
G
Dusp7
dual specificity phosphatase 7
decreases expression
EXP
Cephaloridine results in decreased expression of DUSP7 mRNA
CTD
PMID:18500788
NCBI chr 8:107,009,369...107,016,404
Ensembl chr 8:107,008,528...107,016,404
G
Dusp9
dual specificity phosphatase 9
increases expression
EXP
Cephaloridine results in increased expression of DUSP9 mRNA
CTD
PMID:18500788
NCBI chr X:151,351,897...151,355,822
Ensembl chr X:151,351,897...151,355,821
G
E2f8
E2F transcription factor 8
increases expression
EXP
Cephaloridine results in increased expression of E2F8 mRNA
CTD
PMID:18500788
NCBI chr 1:98,565,717...98,584,265
Ensembl chr 1:98,565,717...98,584,098
G
Edrf1
erythroid differentiation regulatory factor 1
decreases expression
EXP
Cephaloridine results in decreased expression of EDRF1 mRNA
CTD
PMID:18500788
NCBI chr 1:188,441,514...188,478,743
Ensembl chr 1:188,441,634...188,478,701
G
Eef2
eukaryotic translation elongation factor 2
increases expression
EXP
Cephaloridine results in increased expression of EEF2 mRNA
CTD
PMID:18172885
NCBI chr 7:8,533,248...8,538,518
Ensembl chr 7:8,533,116...8,559,183
G
Egr1
early growth response 1
decreases expression
EXP
Cephaloridine results in decreased expression of EGR1 mRNA
CTD
PMID:18500788
NCBI chr18:26,462,967...26,466,766
Ensembl chr18:26,462,981...26,466,766
G
Egr2
early growth response 2
decreases expression
EXP
Cephaloridine results in decreased expression of EGR2 mRNA
CTD
PMID:18500788
NCBI chr20:21,051,270...21,056,322
Ensembl chr20:21,051,277...21,055,562
G
Eif4h
eukaryotic translation initiation factor 4H
increases expression
EXP
Cephaloridine results in increased expression of EIF4H mRNA
CTD
PMID:18172885
NCBI chr12:22,083,155...22,099,876
Ensembl chr12:22,082,835...22,099,876
G
Elf3
E74 like ETS transcription factor 3
increases expression
EXP
Cephaloridine results in increased expression of ELF3 mRNA
CTD
PMID:18500788
NCBI chr13:46,690,460...46,695,394
Ensembl chr13:46,690,466...46,695,481
G
Emb
embigin
increases expression
EXP
Cephaloridine results in increased expression of EMB mRNA
CTD
PMID:18500788
NCBI chr 2:49,070,509...49,125,042
Ensembl chr 2:49,069,087...49,125,050
G
Eme1
essential meiotic structure-specific endonuclease 1
decreases expression
EXP
Cephaloridine results in decreased expression of EME1 mRNA
CTD
PMID:18500788
NCBI chr10:79,586,718...79,595,515
Ensembl chr10:79,586,729...79,595,435
G
Enc1
ectodermal-neural cortex 1
increases expression
EXP
Cephaloridine results in increased expression of ENC1 mRNA
CTD
PMID:18500788
NCBI chr 2:28,550,670...28,562,591
Ensembl chr 2:28,550,464...28,562,713
G
Eno2
enolase 2
increases expression
EXP
Cephaloridine results in increased expression of ENO2 mRNA
CTD
PMID:18500788
NCBI chr 4:157,572,085...157,580,971
Ensembl chr 4:157,572,088...157,580,980
G
Entrep1
endosomal transmembrane epsin interactor 1
increases expression
EXP
Cephaloridine results in increased expression of ENTREP1 mRNA
CTD
PMID:18500788
NCBI chr 1:221,592,500...221,646,603
Ensembl chr 1:221,592,503...221,646,758
G
Espl1
extra spindle pole bodies like 1, separase
decreases expression
EXP
Cephaloridine results in decreased expression of ESPL1 mRNA
CTD
PMID:18500788
NCBI chr 7:133,424,027...133,450,984
Ensembl chr 7:133,424,130...133,450,984
G
Exo1
exonuclease 1
increases expression
EXP
Cephaloridine results in increased expression of EXO1 mRNA
CTD
PMID:18500788
NCBI chr13:87,809,725...87,834,654
Ensembl chr13:87,809,810...87,834,654
G
F13b
coagulation factor XIII B chain
decreases expression
EXP
Cephaloridine results in decreased expression of F13B mRNA
CTD
PMID:18500788
NCBI chr13:51,130,908...51,156,383
Ensembl chr13:51,130,920...51,156,381
G
Fam111a
FAM111 trypsin like peptidase A
decreases expression
EXP
Cephaloridine results in decreased expression of FAM111A mRNA
CTD
PMID:18500788
NCBI chr 1:209,640,865...209,656,551
Ensembl chr 1:209,640,953...209,656,547
G
Fancd2
FA complementation group D2
increases expression
EXP
Cephaloridine results in increased expression of FANCD2 mRNA
CTD
PMID:18500788
NCBI chr 4:146,679,014...146,743,422
Ensembl chr 4:146,679,179...146,743,412
G
Fbln1
fibulin 1
increases expression
EXP
Cephaloridine results in increased expression of FBLN1 mRNA
CTD
PMID:18500788
NCBI chr 7:116,310,582...116,390,075
Ensembl chr 7:116,310,582...116,390,075
G
Fbp2
fructose-bisphosphatase 2
increases expression
EXP
Cephaloridine results in increased expression of FBP2 mRNA
CTD
PMID:18500788
NCBI chr17:2,236,088...2,253,702
Ensembl chr17:2,236,336...2,253,698
G
Fbxo5
F-box protein 5
increases expression
EXP
Cephaloridine results in increased expression of FBXO5 mRNA
CTD
PMID:18500788
NCBI chr 1:42,196,068...42,202,437
Ensembl chr 1:42,196,068...42,202,437
G
Fcgr2a
Fc gamma receptor 2A
increases expression
EXP
Cephaloridine results in increased expression of FCGR2A mRNA
CTD
PMID:18500788
NCBI chr13:83,280,782...83,297,535
Ensembl chr13:83,280,784...83,295,967
G
Fcgr2b
Fc gamma receptor 2B
increases expression
EXP
Cephaloridine results in increased expression of FCGR2B mRNA
CTD
PMID:18500788
NCBI chr13:83,191,253...83,207,778
Ensembl chr13:83,193,163...83,207,778
G
Fcgr3a
Fc gamma receptor 3A
increases expression
EXP
Cephaloridine results in increased expression of FCGR3A mRNA
CTD
PMID:18500788
NCBI chr13:83,249,905...83,259,921
Ensembl chr13:83,249,872...83,259,921
G
Fcnb
ficolin B
increases expression
EXP
Cephaloridine results in increased expression of FCNB mRNA
CTD
PMID:18500788
NCBI chr 3:11,393,713...11,402,198
Ensembl chr 3:11,393,739...11,402,151
G
Fen1
flap structure-specific endonuclease 1
increases expression
EXP
Cephaloridine results in increased expression of FEN1 mRNA
CTD
PMID:18500788
NCBI chr 1:206,845,126...206,849,821
Ensembl chr 1:206,844,884...206,850,003
G
Fgb
fibrinogen beta chain
increases expression
EXP
Cephaloridine results in increased expression of FGB mRNA
CTD
PMID:18500788
NCBI chr 2:168,394,901...168,402,863
Ensembl chr 2:168,394,916...168,405,979
G
Fgf17
fibroblast growth factor 17
increases expression
EXP
Cephaloridine results in increased expression of FGF17 mRNA
CTD
PMID:18500788
NCBI chr15:45,711,498...45,717,622
Ensembl chr15:45,711,998...45,717,063
G
Fgl2
fibrinogen-like 2
increases expression
EXP
Cephaloridine results in increased expression of FGL2 mRNA
CTD
PMID:18500788
NCBI chr 4:13,710,566...13,716,207
Ensembl chr 4:13,710,575...13,716,207
G
Fhdc1
FH2 domain containing 1
increases expression
EXP
Cephaloridine results in increased expression of FHDC1 mRNA
CTD
PMID:18500788
NCBI chr 2:169,790,917...169,829,580
Ensembl chr 2:169,790,947...169,827,896
G
Filip1
filamin A interacting protein 1
decreases expression
EXP
Cephaloridine results in decreased expression of FILIP1 mRNA
CTD
PMID:18500788
NCBI chr 8:80,761,283...80,956,556
Ensembl chr 8:80,764,604...80,922,549
G
Folh1
folate hydrolase 1
decreases expression
EXP
Cephaloridine results in decreased expression of FOLH1 mRNA
CTD
PMID:18500788
NCBI chr 1:140,428,101...140,501,563
Ensembl chr 1:140,428,101...140,501,379
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
decreases expression
EXP
Cephaloridine results in decreased expression of FOS mRNA
CTD
PMID:18500788
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
G
Foxe1
forkhead box E1
decreases expression
EXP
Cephaloridine results in decreased expression of FOXE1 mRNA
CTD
PMID:18500788
NCBI chr 5:60,630,027...60,632,835
Ensembl chr 5:60,630,027...60,632,835
G
Foxq1
forkhead box Q1
increases expression
EXP
Cephaloridine results in increased expression of FOXQ1 mRNA
CTD
PMID:18500788
NCBI chr17:32,912,744...32,915,377
Ensembl chr17:32,912,744...32,915,377 Ensembl chr17:32,912,744...32,915,377
G
Fyco1
FYVE and coiled-coil domain autophagy adaptor 1
decreases expression
EXP
Cephaloridine results in decreased expression of FYCO1 mRNA
CTD
PMID:18500788
NCBI chr 8:123,412,105...123,479,315
Ensembl chr 8:123,412,112...123,479,021
G
G6pc1
glucose-6-phosphatase catalytic subunit 1
decreases expression
EXP
Cephaloridine results in decreased expression of G6PC1 mRNA
CTD
PMID:18500788
NCBI chr10:86,307,400...86,318,766
Ensembl chr10:86,257,668...86,333,804
G
G6pd
glucose-6-phosphate dehydrogenase
increases expression
EXP
Cephaloridine results in increased expression of G6PD mRNA
CTD
PMID:18500788
NCBI chr X:152,201,081...152,220,863
Ensembl chr X:152,201,098...152,220,801
G
Gadd45a
growth arrest and DNA-damage-inducible, alpha
increases expression
EXP
Cephaloridine results in increased expression of GADD45A mRNA
CTD
PMID:18172885
NCBI chr 4:96,154,789...96,157,091
Ensembl chr 4:96,154,789...96,157,115
G
Galnt13
polypeptide N-acetylgalactosaminyltransferase 13
increases expression
EXP
Cephaloridine results in increased expression of GALNT13 mRNA
CTD
PMID:18500788
NCBI chr 3:38,903,695...39,560,683
Ensembl chr 3:38,974,490...39,558,803
G
Ganc
glucosidase, alpha; neutral C
decreases expression
EXP
Cephaloridine results in decreased expression of GANC mRNA
CTD
PMID:18500788
NCBI chr 3:107,353,369...107,406,104
Ensembl chr 3:107,353,369...107,405,241
G
Garin4
golgi associated RAB2 interactor family member 4
increases expression
EXP
Cephaloridine results in increased expression of GARIN4 mRNA
CTD
PMID:18500788
NCBI chr13:102,742,988...102,745,168
Ensembl chr13:102,742,988...102,745,168
G
Gba3
glucosylceramidase beta 3
decreases expression
EXP
Cephaloridine results in decreased expression of GBA3 mRNA
CTD
PMID:18500788
NCBI chr14:60,574,974...60,721,411
Ensembl chr14:60,574,976...60,721,653
G
Gda
guanine deaminase
increases expression
EXP
Cephaloridine results in increased expression of GDA mRNA
CTD
PMID:18500788
NCBI chr 1:218,903,045...218,982,360
Ensembl chr 1:218,906,815...218,982,416
G
Gdf15
growth differentiation factor 15
decreases expression
EXP
Cephaloridine results in decreased expression of GDF15 mRNA
CTD
PMID:18500788
NCBI chr16:18,804,457...18,808,043
Ensembl chr16:18,805,239...18,808,055
G
Gfra2
GDNF family receptor alpha 2
decreases expression
EXP
Cephaloridine results in decreased expression of GFRA2 mRNA
CTD
PMID:18500788
NCBI chr15:45,941,841...46,033,715
Ensembl chr15:45,941,828...46,033,714
G
Gins2
GINS complex subunit 2
increases expression
EXP
Cephaloridine results in increased expression of GINS2 mRNA
CTD
PMID:18500788
NCBI chr19:48,626,770...48,639,523
Ensembl chr19:48,626,770...48,639,339
G
Gins4
GINS complex subunit 4
increases expression
EXP
Cephaloridine results in increased expression of GINS4 mRNA
CTD
PMID:18500788
NCBI chr16:68,787,572...68,799,938
Ensembl chr16:68,767,339...68,802,273
G
Gmnn
geminin, DNA replication inhibitor
increases expression
EXP
Cephaloridine results in increased expression of GMNN mRNA
CTD
PMID:18500788
NCBI chr17:40,301,771...40,310,054
Ensembl chr17:40,301,808...40,310,054
G
Gna14
G protein subunit alpha 14
increases expression
EXP
Cephaloridine results in increased expression of GNA14 mRNA
CTD
PMID:18500788
NCBI chr 1:213,714,993...213,900,083
Ensembl chr 1:213,716,020...213,897,423
G
Gpnmb
glycoprotein nmb
increases expression
EXP
Cephaloridine results in increased expression of GPNMB mRNA
CTD
PMID:18500788
NCBI chr 4:78,010,247...78,031,491
Ensembl chr 4:78,010,197...78,049,367
G
Gpr135
G protein-coupled receptor 135
decreases expression
EXP
Cephaloridine results in decreased expression of GPR135 mRNA
CTD
PMID:18500788
NCBI chr 6:90,627,533...90,630,661
Ensembl chr 6:90,629,178...90,630,551
G
Gpr19
G protein-coupled receptor 19
increases expression
EXP
Cephaloridine results in increased expression of GPR19 mRNA
CTD
PMID:18500788
NCBI chr 4:167,710,944...167,739,232
Ensembl chr 4:167,710,666...167,741,036
G
Gpx2
glutathione peroxidase 2
increases expression
EXP
Cephaloridine results in increased expression of GPX2 mRNA
CTD
PMID:18500788
NCBI chr 6:95,493,589...95,496,877
Ensembl chr 6:95,493,589...95,496,877
G
Gria3
glutamate ionotropic receptor AMPA type subunit 3
decreases expression
EXP
Cephaloridine results in decreased expression of GRIA3 mRNA
CTD
PMID:18500788
NCBI chr X:120,238,515...120,504,106
Ensembl chr X:120,238,534...120,504,096
G
Gsr
glutathione-disulfide reductase
increases expression
EXP
Cephaloridine results in increased expression of GSR mRNA
CTD
PMID:18172885
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
G
Gsta2
glutathione S-transferase alpha 2
increases expression
EXP
Cephaloridine results in increased expression of GSTA2 mRNA
CTD
PMID:18172885
NCBI chr 8:79,184,535...79,196,827
Ensembl chr 8:79,184,322...79,196,798
G
Gsta5
glutathione S-transferase alpha 5
increases expression
EXP
Cephaloridine results in increased expression of GSTA5 mRNA
CTD
PMID:18172885
NCBI chr 8:79,105,561...79,117,472
Ensembl chr 8:79,105,661...79,117,472
G
Gstm1
glutathione S-transferase mu 1
increases expression
EXP
Cephaloridine results in increased expression of GSTM1 mRNA
CTD
PMID:18172885 PMID:18500788
NCBI chr 2:195,649,845...195,655,402
Ensembl chr 2:195,649,845...195,655,411
G
Gstp1
glutathione S-transferase pi 1
increases expression
EXP
Cephaloridine results in increased expression of GSTP1 mRNA
CTD
PMID:18500788
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
G
Gxylt1
glucoside xylosyltransferase 1
decreases expression
EXP
Cephaloridine results in decreased expression of GXYLT1 mRNA
CTD
PMID:18500788
NCBI chr 7:124,400,896...124,434,682
Ensembl chr 7:124,400,896...124,434,699
G
H1f1
H1.1 linker histone, cluster member
increases expression
EXP
Cephaloridine results in increased expression of H1F1 mRNA
CTD
PMID:18500788
NCBI chr17:41,366,268...41,367,011
Ensembl chr17:41,366,268...41,367,011
G
Hadh
hydroxyacyl-CoA dehydrogenase
decreases expression
EXP
Cephaloridine results in decreased expression of HADH mRNA
CTD
PMID:18500788
NCBI chr 2:219,787,935...219,830,335
Ensembl chr 2:219,787,927...219,830,353
G
Haus8
HAUS augmin-like complex, subunit 8
increases expression
EXP
Cephaloridine results in increased expression of HAUS8 mRNA
CTD
PMID:18500788
NCBI chr16:17,930,819...17,945,254
Ensembl chr16:17,930,820...17,945,237
G
Havcr1
hepatitis A virus cellular receptor 1
increases expression
EXP
Cephaloridine results in increased expression of HAVCR1 mRNA
CTD
PMID:18500788 PMID:20305092
NCBI chr10:31,118,667...31,151,730
Ensembl chr10:31,119,088...31,151,698
G
Hck
HCK proto-oncogene, Src family tyrosine kinase
increases expression
EXP
Cephaloridine results in increased expression of HCK mRNA
CTD
PMID:18500788
NCBI chr 3:141,571,587...141,614,696
Ensembl chr 3:141,571,587...141,614,693
G
Hebp1
heme binding protein 1
increases expression
EXP
Cephaloridine results in increased expression of HEBP1 mRNA
CTD
PMID:18500788
NCBI chr 4:167,974,316...168,003,854
Ensembl chr 4:167,974,319...168,003,854
G
Hebp2
heme binding protein 2
increases expression
EXP
Cephaloridine results in increased expression of HEBP2 mRNA
CTD
PMID:18500788
NCBI chr 1:13,194,982...13,201,777
Ensembl chr 1:13,194,982...13,201,777
G
Hells
helicase, lymphoid specific
increases expression
EXP
Cephaloridine results in increased expression of HELLS mRNA
CTD
PMID:18500788
NCBI chr 1:236,701,704...236,748,239
Ensembl chr 1:236,701,758...236,746,844
G
Hepacam2
HEPACAM family member 2
increases expression
EXP
Cephaloridine results in increased expression of HEPACAM2 mRNA
CTD
PMID:18500788
NCBI chr 4:31,446,195...31,480,859
Ensembl chr 4:31,446,169...31,480,953
G
Hjv
hemojuvelin BMP co-receptor
decreases expression
EXP
Cephaloridine results in decreased expression of HJV mRNA
CTD
PMID:18500788
NCBI chr 2:184,065,944...184,069,851
Ensembl chr 2:184,065,970...184,069,850
G
Hlx
H2.0-like homeobox
decreases expression
EXP
Cephaloridine results in decreased expression of HLX mRNA
CTD
PMID:18500788
NCBI chr13:96,280,335...96,285,750
Ensembl chr13:96,280,339...96,285,750
G
Hmgcs2
3-hydroxy-3-methylglutaryl-CoA synthase 2
decreases expression
EXP
Cephaloridine results in decreased expression of HMGCS2 mRNA
CTD
PMID:18500788
NCBI chr 2:185,875,609...185,903,505
Ensembl chr 2:185,875,616...185,902,130
G
Hmox1
heme oxygenase 1
increases expression
EXP
Cephaloridine results in increased expression of HMOX1 mRNA
CTD
PMID:18172885 PMID:18500788
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Hmx3
H6 family homeobox 3
increases expression
EXP
Cephaloridine results in increased expression of HMX3 mRNA
CTD
PMID:18500788
NCBI chr 1:186,313,237...186,315,201
Ensembl chr 1:186,313,063...186,315,201
G
Hnrnpa1
heterogeneous nuclear ribonucleoprotein A1
increases expression
EXP
Cephaloridine results in increased expression of HNRNPA1 mRNA
CTD
PMID:18500788
NCBI chr 7:134,375,318...134,381,610
Ensembl chr 7:134,375,150...134,381,609
G
Hnrnpa1-ps28
heterogeneous nuclear ribonucleoprotein A1, pseudogene 28
increases expression
EXP
Cephaloridine results in increased expression of HNRNPA1-PS28 mRNA
CTD
PMID:18500788
NCBI chr X:107,752,105...107,759,183
G
Hrg
histidine-rich glycoprotein
decreases expression
EXP
Cephaloridine results in decreased expression of HRG mRNA
CTD
PMID:18500788
NCBI chr11:78,054,488...78,069,402
Ensembl chr11:78,054,498...78,069,389
G
Hsd17b2
hydroxysteroid (17-beta) dehydrogenase 2
decreases expression
EXP
Cephaloridine results in decreased expression of HSD17B2 mRNA
CTD
PMID:18500788
NCBI chr19:45,753,576...45,825,203
Ensembl chr19:45,753,574...45,825,202
G
Hsd3b1
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1
increases expression
EXP
Cephaloridine results in increased expression of HSD3B1 mRNA
CTD
PMID:18500788
NCBI chr 2:186,169,864...186,175,984
Ensembl chr 2:186,169,863...186,175,999
G
Hsp90aa1
heat shock protein 90 alpha family class A member 1
increases expression
EXP
Cephaloridine results in increased expression of HSP90AA1 mRNA
CTD
PMID:18500788
NCBI chr 6:129,702,376...129,707,907
Ensembl chr 6:129,702,383...129,707,268
G
Hspa1a
heat shock protein family A (Hsp70) member 1A
increases expression
EXP
Cephaloridine results in increased expression of HSPA1A mRNA
CTD
PMID:18500788
NCBI chr20:3,870,765...3,873,221
Ensembl chr20:3,856,006...3,873,227
G
Hspa1b
heat shock protein family A (Hsp70) member 1B
increases expression
EXP
Cephaloridine results in increased expression of HSPA1B mRNA
CTD
PMID:18500788
NCBI chr20:3,855,104...3,859,148
Ensembl chr20:3,856,006...3,873,240 Ensembl chr20:3,856,006...3,873,240
G
Hsph1
heat shock protein family H (Hsp110) member 1
increases expression
EXP
Cephaloridine results in increased expression of HSPH1 mRNA
CTD
PMID:18500788
NCBI chr12:5,390,916...5,410,224
Ensembl chr12:5,390,922...5,410,224
G
Htatip2
HIV-1 Tat interactive protein 2
increases expression
EXP
Cephaloridine results in increased expression of HTATIP2 mRNA
CTD
PMID:18500788
NCBI chr 1:99,473,411...99,488,632
Ensembl chr 1:99,469,245...99,488,629
G
Htr5b
5-hydroxytryptamine (serotonin) receptor 5B
increases expression
EXP
Cephaloridine results in increased expression of HTR5B mRNA
CTD
PMID:18500788
NCBI chr13:32,686,911...32,699,835
Ensembl chr13:32,687,042...32,699,835
G
Icam1
intercellular adhesion molecule 1
increases expression
EXP
Cephaloridine results in increased expression of ICAM1 mRNA
CTD
PMID:18500788
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
G
Idi2l3
isopentenyl-diphosphate delta isomerase 2 like 3
decreases expression
EXP
Cephaloridine results in decreased expression of IDI2L3 mRNA
CTD
PMID:18500788
NCBI chr17:61,518,138...61,535,484
Ensembl chr17:61,519,390...61,531,603
G
Ier3
immediate early response 3
decreases expression
EXP
Cephaloridine results in decreased expression of IER3 mRNA
CTD
PMID:18500788
NCBI chr20:2,928,378...2,929,582
Ensembl chr20:2,928,378...2,929,583
G
Ifitm10
interferon induced transmembrane protein 10
increases expression
EXP
Cephaloridine results in increased expression of IFITM10 mRNA
CTD
PMID:18500788
NCBI chr 1:197,507,501...197,524,180
Ensembl chr 1:197,507,503...197,525,151
G
Il18
interleukin 18
increases expression
EXP
Cephaloridine results in increased expression of IL18 mRNA
CTD
PMID:18500788
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
G
Il1b
interleukin 1 beta
decreases expression
EXP
Cephaloridine results in decreased expression of IL1B mRNA
CTD
PMID:18500788
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il20ra
interleukin 20 receptor subunit alpha
decreases expression
EXP
Cephaloridine results in decreased expression of IL20RA mRNA
CTD
PMID:18500788
NCBI chr 1:14,424,215...14,494,226
Ensembl chr 1:14,451,228...14,493,602
G
Inhbb
inhibin subunit beta B
decreases expression
EXP
Cephaloridine results in decreased expression of INHBB mRNA
CTD
PMID:18500788
NCBI chr13:30,530,860...30,536,566
Ensembl chr13:30,530,860...30,537,832
G
Itpka
inositol-trisphosphate 3-kinase A
increases expression
EXP
Cephaloridine results in increased expression of ITPKA mRNA
CTD
PMID:18500788
NCBI chr 3:106,726,036...106,734,601
Ensembl chr 3:106,726,036...106,734,600
G
Itpkb
inositol-trisphosphate 3-kinase B
increases expression
EXP
Cephaloridine results in increased expression of ITPKB mRNA
CTD
PMID:18500788
NCBI chr13:92,069,160...92,164,281
Ensembl chr13:92,069,216...92,162,004
G
Jade2
jade family PHD finger 2
decreases expression
EXP
Cephaloridine results in decreased expression of JADE2 mRNA
CTD
PMID:18500788
NCBI chr10:36,075,239...36,124,210
Ensembl chr10:36,078,917...36,116,984
G
Jun
Jun proto-oncogene, AP-1 transcription factor subunit
increases expression
EXP
Cephaloridine results in increased expression of JUN mRNA
CTD
PMID:18172885
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
G
Junb
JunB proto-oncogene, AP-1 transcription factor subunit
decreases expression increases expression
EXP
Cephaloridine results in decreased expression of JUNB mRNA Cephaloridine results in increased expression of JUNB mRNA
CTD
PMID:18172885 PMID:18500788
NCBI chr19:23,176,265...23,178,049
Ensembl chr19:23,176,294...23,178,035
G
Kbtbd11
kelch repeat and BTB domain containing 11
decreases expression
EXP
Cephaloridine results in decreased expression of KBTBD11 mRNA
CTD
PMID:18500788
NCBI chr16:74,618,291...74,638,010
Ensembl chr16:74,615,792...74,637,736
G
Kcnh1
potassium voltage-gated channel subfamily H member 1
increases expression
EXP
Cephaloridine results in increased expression of KCNH1 mRNA
CTD
PMID:18500788
NCBI chr13:103,722,140...104,024,762
Ensembl chr13:103,722,245...104,024,740
G
Kcnj15
potassium inwardly-rectifying channel, subfamily J, member 15
decreases expression
EXP
Cephaloridine results in decreased expression of KCNJ15 mRNA
CTD
PMID:18500788
NCBI chr11:34,577,397...34,621,725
Ensembl chr11:34,577,363...34,621,952
G
Kctd1
potassium channel tetramerization domain containing 1
increases expression
EXP
Cephaloridine results in increased expression of KCTD1 mRNA
CTD
PMID:18500788
NCBI chr18:6,122,390...6,316,434
Ensembl chr18:6,122,390...6,317,393
G
Kgd4
alpha-ketoglutarate dehydrogenase subunit 4
increases expression
EXP
Cephaloridine results in increased expression of KGD4 mRNA
CTD
PMID:18500788
NCBI chr 2:31,870,549...31,878,335
Ensembl chr 2:31,870,551...31,880,730
G
Kif18a
kinesin family member 18A
decreases expression
EXP
Cephaloridine results in decreased expression of KIF18A mRNA
CTD
PMID:18500788
NCBI chr 3:95,764,388...95,824,756
Ensembl chr 3:95,764,388...95,824,582
G
Kif2c
kinesin family member 2C
decreases expression
EXP
Cephaloridine results in decreased expression of KIF2C mRNA
CTD
PMID:18500788
NCBI chr 5:130,637,347...130,662,680
Ensembl chr 5:130,637,347...130,662,637
G
Klf7
KLF transcription factor 7
decreases expression
EXP
Cephaloridine results in decreased expression of KLF7 mRNA
CTD
PMID:18500788
NCBI chr 9:65,433,683...65,526,372
Ensembl chr 9:65,437,167...65,526,261
G
Klhl25
kelch-like family member 25
decreases expression
EXP
Cephaloridine results in decreased expression of KLHL25 mRNA
CTD
PMID:18500788
NCBI chr 1:129,724,894...129,750,142
Ensembl chr 1:129,722,026...129,750,227
G
Knstrn
kinetochore-localized astrin/SPAG5 binding protein
decreases expression
EXP
Cephaloridine results in decreased expression of KNSTRN mRNA
CTD
PMID:18500788
NCBI chr 3:105,800,762...105,820,555
Ensembl chr 3:105,800,954...105,820,715
G
Kntc1
kinetochore associated 1
increases expression
EXP
Cephaloridine results in increased expression of KNTC1 mRNA
CTD
PMID:18500788
NCBI chr12:32,769,020...32,839,617
Ensembl chr12:32,769,020...32,839,561
G
Lama2
laminin subunit alpha 2
decreases expression
EXP
Cephaloridine results in decreased expression of LAMA2 mRNA
CTD
PMID:18500788
NCBI chr 1:17,672,675...18,320,641
Ensembl chr 1:17,672,536...18,320,530
G
Lamb3
laminin subunit beta 3
increases expression
EXP
Cephaloridine results in increased expression of LAMB3 mRNA
CTD
PMID:18500788
NCBI chr13:104,833,810...104,875,405
Ensembl chr13:104,833,873...104,875,405
G
Lars1
leucyl-tRNA synthetase 1
decreases expression
EXP
Cephaloridine results in decreased expression of LARS1 mRNA
CTD
PMID:18500788
NCBI chr18:34,201,555...34,256,003
Ensembl chr18:34,201,549...34,255,931
G
Lcor
ligand dependent nuclear receptor corepressor
decreases expression
EXP
Cephaloridine results in decreased expression of LCOR mRNA
CTD
PMID:18500788
NCBI chr 1:240,298,565...240,405,627
Ensembl chr 1:240,298,563...240,402,448
G
Lect2
leukocyte cell-derived chemotaxin 2
decreases expression
EXP
Cephaloridine results in decreased expression of LECT2 mRNA
CTD
PMID:18500788
NCBI chr17:8,044,759...8,050,983
Ensembl chr17:8,044,759...8,050,983
G
Lgals2
galectin 2
increases expression
EXP
Cephaloridine results in increased expression of LGALS2 mRNA
CTD
PMID:18500788
NCBI chr 7:110,403,171...110,410,046
Ensembl chr 7:110,403,173...110,404,802
G
Lgals3
galectin 3
increases expression
EXP
Cephaloridine results in increased expression of LGALS3 mRNA
CTD
PMID:18500788
NCBI chr15:20,620,083...20,632,019
Ensembl chr15:20,607,692...20,632,025
G
Lhx3
LIM homeobox 3
decreases expression
EXP
Cephaloridine results in decreased expression of LHX3 mRNA
CTD
PMID:18500788
NCBI chr 3:9,026,432...9,035,122
Ensembl chr 3:9,027,425...9,034,480
G
Lig1
DNA ligase 1
increases expression
EXP
Cephaloridine results in increased expression of LIG1 mRNA
CTD
PMID:18500788
NCBI chr 1:74,165,688...74,204,400
Ensembl chr 1:74,165,842...74,204,413
G
Lmnb1
lamin B1
decreases expression
EXP
Cephaloridine results in decreased expression of LMNB1 mRNA
CTD
PMID:18500788
NCBI chr18:50,175,861...50,215,210
Ensembl chr18:50,175,874...50,214,502
G
Lratd1
LRAT domain containing 1
increases expression
EXP
Cephaloridine results in increased expression of LRATD1 mRNA
CTD
PMID:18500788
NCBI chr 6:36,916,969...36,922,143
Ensembl chr 6:36,913,469...36,922,319
G
Lrrn3
leucine rich repeat neuronal 3
decreases expression
EXP
Cephaloridine results in decreased expression of LRRN3 mRNA
CTD
PMID:18500788
NCBI chr 6:58,489,060...58,520,322
Ensembl chr 6:58,489,010...58,520,330
G
Maf
MAF bZIP transcription factor
decreases expression
EXP
Cephaloridine results in decreased expression of MAF mRNA
CTD
PMID:18500788
NCBI chr19:43,353,867...43,713,162
Ensembl chr19:43,360,342...43,712,365
G
Map3k1
mitogen-activated protein kinase kinase kinase 1
increases expression
EXP
Cephaloridine results in increased expression of MAP3K1 mRNA
CTD
PMID:18172885
NCBI chr 2:43,348,572...43,414,706
Ensembl chr 2:43,350,098...43,414,463
G
Map3k12
mitogen activated protein kinase kinase kinase 12
decreases expression
EXP
Cephaloridine results in decreased expression of MAP3K12 mRNA
CTD
PMID:18172885
NCBI chr 7:133,630,267...133,648,464
Ensembl chr 7:133,630,835...133,640,789
G
Mapk1
mitogen activated protein kinase 1
multiple interactions increases activity increases phosphorylation
EXP
Thymic Factor, Circulating inhibits the reaction [Cephaloridine results in increased phosphorylation of MAPK1 protein] Cephaloridine results in increased activity of MAPK1 protein
CTD
PMID:16154539 PMID:16272694
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
G
Mapk3
mitogen activated protein kinase 3
increases activity increases phosphorylation multiple interactions
EXP
Cephaloridine results in increased activity of MAPK3 protein Cephaloridine results in increased phosphorylation of MAPK3 protein Thymic Factor, Circulating inhibits the reaction [Cephaloridine results in increased phosphorylation of MAPK3 protein]
CTD
PMID:16154539 PMID:16272694
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
G
Mapk8ip3
mitogen-activated protein kinase 8 interacting protein 3
increases expression
EXP
Cephaloridine results in increased expression of MAPK8IP3 mRNA
CTD
PMID:18500788
NCBI chr10:13,918,417...13,958,335
Ensembl chr10:13,918,400...13,958,273
G
Masp2
MBL associated serine protease 2
increases expression
EXP
Cephaloridine results in increased expression of MASP2 mRNA
CTD
PMID:18500788
NCBI chr 5:159,035,892...159,049,561
Ensembl chr 5:159,035,911...159,049,580
G
Mcm2
minichromosome maintenance complex component 2
increases expression
EXP
Cephaloridine results in increased expression of MCM2 mRNA
CTD
PMID:18500788
NCBI chr 4:121,346,434...121,360,962
Ensembl chr 4:121,346,434...121,360,847
G
Mcm3
minichromosome maintenance complex component 3
increases expression
EXP
Cephaloridine results in increased expression of MCM3 mRNA
CTD
PMID:18500788
NCBI chr 9:23,219,169...23,237,314
Ensembl chr 9:23,219,169...23,237,314
G
Mcm5
minichromosome maintenance complex component 5
increases expression
EXP
Cephaloridine results in increased expression of MCM5 mRNA
CTD
PMID:18500788
NCBI chr19:13,483,030...13,504,389
Ensembl chr19:13,483,066...13,504,389
G
Mcm6
minichromosome maintenance complex component 6
increases expression
EXP
Cephaloridine results in increased expression of MCM6 mRNA
CTD
PMID:18500788
NCBI chr13:39,826,745...39,851,937
Ensembl chr13:39,826,763...39,851,960
G
Mcm7
minichromosome maintenance complex component 7
increases expression
EXP
Cephaloridine results in increased expression of MCM7 mRNA
CTD
PMID:18500788
NCBI chr12:17,042,207...17,049,470
Ensembl chr12:17,042,212...17,050,063
G
Mcm8
minichromosome maintenance 8 homologous recombination repair factor
increases expression
EXP
Cephaloridine results in increased expression of MCM8 mRNA
CTD
PMID:18500788
NCBI chr 3:120,086,741...120,117,008
Ensembl chr 3:120,086,763...120,117,008
G
Mesp1
mesoderm posterior bHLH transcription factor 1
decreases expression
EXP
Cephaloridine results in decreased expression of MESP1 mRNA
CTD
PMID:18500788
NCBI chr 1:133,738,357...133,739,875
Ensembl chr 1:133,738,357...133,739,875
G
Met
MET proto-oncogene, receptor tyrosine kinase
increases expression
EXP
Cephaloridine results in increased expression of MET mRNA
CTD
PMID:18172885
NCBI chr 4:45,790,456...45,898,139
Ensembl chr 4:45,790,791...45,897,876
G
Mgll
monoglyceride lipase
decreases expression
EXP
Cephaloridine results in decreased expression of MGLL mRNA
CTD
PMID:18500788
NCBI chr 4:121,192,186...121,294,187
Ensembl chr 4:121,192,195...121,294,179
G
Mki67
marker of proliferation Ki-67
decreases expression
EXP
Cephaloridine results in decreased expression of MKI67 mRNA
CTD
PMID:18500788
NCBI chr 1:190,496,319...190,522,983
Ensembl chr 1:190,496,319...190,522,762
G
Mmp12
matrix metallopeptidase 12
increases expression
EXP
Cephaloridine results in increased expression of MMP12 mRNA
CTD
PMID:18500788
NCBI chr 8:4,581,785...4,591,687
Ensembl chr 8:4,581,785...4,599,611
G
Mmp16
matrix metallopeptidase 16
increases expression
EXP
Cephaloridine results in increased expression of MMP16 mRNA
CTD
PMID:18500788
NCBI chr 5:31,312,280...31,556,276
Ensembl chr 5:31,312,280...31,548,388
G
Mnd1
meiotic nuclear divisions 1
increases expression
EXP
Cephaloridine results in increased expression of MND1 mRNA
CTD
PMID:18500788
NCBI chr 2:169,433,523...169,496,081
Ensembl chr 2:169,433,540...169,496,096
G
Mns1
meiosis-specific nuclear structural 1
decreases expression
EXP
Cephaloridine results in decreased expression of MNS1 mRNA
CTD
PMID:18500788
NCBI chr 8:73,148,877...73,169,570
Ensembl chr 8:73,148,877...73,176,925
G
Mpst
mercaptopyruvate sulfurtransferase
decreases expression
EXP
Cephaloridine results in decreased expression of MPST mRNA
CTD
PMID:18500788
NCBI chr 7:109,955,581...109,963,155
Ensembl chr 7:109,955,675...109,963,141
G
Mpv17l
MPV17 mitochondrial inner membrane protein like
decreases expression
EXP
Cephaloridine results in decreased expression of MPV17L mRNA
CTD
PMID:18500788
NCBI chr10:1,988,451...2,025,300
Ensembl chr10:1,988,136...2,007,649
G
Mt1
metallothionein 1
decreases expression
EXP
Cephaloridine results in decreased expression of MT1A mRNA
CTD
PMID:18172885
NCBI chr19:10,826,032...10,827,048
Ensembl chr19:10,826,032...10,827,049 Ensembl chr17:10,826,032...10,827,049 Ensembl chr X:10,826,032...10,827,049
G
Mthfd1l
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1-like
increases expression
EXP
Cephaloridine results in increased expression of MTHFD1L mRNA
CTD
PMID:18500788
NCBI chr 1:40,443,926...40,632,911
Ensembl chr 1:40,444,008...40,632,905
G
Mthfd2
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase
increases expression
EXP
Cephaloridine results in increased expression of MTHFD2 mRNA
CTD
PMID:18500788
NCBI chr 4:115,811,135...115,822,663
Ensembl chr 4:115,811,139...115,822,608
G
Myom3
myomesin 3
increases expression
EXP
Cephaloridine results in increased expression of MYOM3 mRNA
CTD
PMID:18500788
NCBI chr 5:147,992,737...148,043,282
Ensembl chr 5:147,992,737...148,043,274
G
Ncor2
nuclear receptor co-repressor 2
decreases expression
EXP
Cephaloridine results in decreased expression of NCOR2 mRNA
CTD
PMID:18500788
NCBI chr12:31,466,418...31,628,319
Ensembl chr12:31,466,412...31,628,319
G
Nek6
NIMA-related kinase 6
increases expression
EXP
Cephaloridine results in increased expression of NEK6 mRNA
CTD
PMID:18500788
NCBI chr 3:22,284,269...22,356,302
Ensembl chr 3:22,284,279...22,395,990
G
Nfil3
nuclear factor, interleukin 3 regulated
increases expression
EXP
Cephaloridine results in increased expression of NFIL3 mRNA
CTD
PMID:18500788
NCBI chr17:12,280,499...12,295,728
Ensembl chr17:12,280,484...12,295,858
G
Nfkbia
NFKB inhibitor alpha
decreases expression
EXP
Cephaloridine results in decreased expression of NFKBIA mRNA
CTD
PMID:18172885
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
G
Nfkbiz
NFKB inhibitor zeta
decreases expression
EXP
Cephaloridine results in decreased expression of NFKBIZ mRNA
CTD
PMID:18500788
NCBI chr11:44,782,676...44,810,722
Ensembl chr11:44,782,676...44,810,723
G
Ngfr
nerve growth factor receptor
increases expression
EXP
Cephaloridine results in increased expression of NGFR mRNA
CTD
PMID:18500788
NCBI chr10:80,515,287...80,533,518
Ensembl chr10:80,515,299...80,533,518
G
Nhp2
NHP2 ribonucleoprotein
increases expression
EXP
Cephaloridine results in increased expression of NHP2 mRNA
CTD
PMID:18500788
NCBI chr10:35,877,057...35,880,399
Ensembl chr10:35,877,054...35,882,545
G
Ninj2
ninjurin 2
increases expression
EXP
Cephaloridine results in increased expression of NINJ2 mRNA
CTD
PMID:18500788
NCBI chr 4:153,306,439...153,408,618
Ensembl chr 4:153,306,553...153,408,617
G
Nipsnap3a
nipsnap homolog 3A (C. elegans)
increases expression
EXP
Cephaloridine results in increased expression of NIPSNAP3B mRNA
CTD
PMID:18500788
NCBI chr 5:67,613,993...67,625,067
Ensembl chr 5:67,614,036...67,669,700
G
Nme4
NME/NM23 nucleoside diphosphate kinase 4
decreases expression
EXP
Cephaloridine results in decreased expression of NME4 mRNA
CTD
PMID:18500788
NCBI chr10:15,114,624...15,118,479
Ensembl chr10:15,002,926...15,118,479
G
Nop56
NOP56 ribonucleoprotein
increases expression
EXP
Cephaloridine results in increased expression of NOP56 mRNA
CTD
PMID:18500788
NCBI chr 3:117,476,963...117,481,847
Ensembl chr 3:117,477,053...117,481,841
G
Nqo1
NAD(P)H quinone dehydrogenase 1
increases expression
EXP
Cephaloridine results in increased expression of NQO1 mRNA
CTD
PMID:18172885 PMID:18500788
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
G
Nr1d1
nuclear receptor subfamily 1, group D, member 1
increases expression
EXP
Cephaloridine results in increased expression of NR1D1 mRNA
CTD
PMID:18500788
NCBI chr10:83,728,348...83,735,562
Ensembl chr10:83,728,318...83,735,705
G
Nrm
nurim
increases expression
EXP
Cephaloridine results in increased expression of NRM mRNA
CTD
PMID:18500788
NCBI chr20:2,888,321...2,892,804
Ensembl chr20:2,877,567...2,891,802
G
Nudt11
nudix hydrolase 11
increases expression
EXP
Cephaloridine results in increased expression of NUDT11 mRNA
CTD
PMID:18500788
NCBI chr X:16,326,775...16,333,396
Ensembl chr X:16,326,598...16,333,145
G
Nudt4
nudix hydrolase 4
increases expression
EXP
Cephaloridine results in increased expression of NUDT10 mRNA
CTD
PMID:18500788
NCBI chr 7:30,188,100...30,204,615
Ensembl chr 7:30,188,100...30,204,615
G
Oprl1
opioid related nociceptin receptor 1
increases expression
EXP
Cephaloridine results in increased expression of OPRL1 mRNA
CTD
PMID:18500788
NCBI chr 3:168,831,934...168,839,920
Ensembl chr 3:168,834,003...168,839,920
G
Or2w6
olfactory receptor family 2 subfamily W member 6
increases expression
EXP
Cephaloridine results in increased expression of OR2W6 mRNA
CTD
PMID:18500788
NCBI chr17:42,906,458...42,907,396
Ensembl chr17:42,904,951...42,919,599
G
Or52b2
olfactory receptor family 52 subfamily B member 2
increases expression
EXP
Cephaloridine results in increased expression of OR52B2 mRNA
CTD
PMID:18500788
NCBI chr 1:159,695,507...159,696,475
Ensembl chr 1:159,694,964...159,701,227
G
Or52k1
olfactory receptor family 52 subfamily K member 1
decreases expression
EXP
Cephaloridine results in decreased expression of OR52K1 mRNA
CTD
PMID:18500788
NCBI chr 1:157,037,381...157,038,325
Ensembl chr 1:157,037,381...157,038,325
G
Orc6
origin recognition complex, subunit 6
increases expression
EXP
Cephaloridine results in increased expression of ORC6 mRNA
CTD
PMID:18500788
NCBI chr19:21,757,867...21,765,638
Ensembl chr19:21,757,866...21,765,662
G
Osbpl8
oxysterol binding protein-like 8
decreases expression
EXP
Cephaloridine results in decreased expression of OSBPL8 mRNA
CTD
PMID:18500788
NCBI chr 7:46,596,944...46,749,888
Ensembl chr 7:46,596,983...46,749,888
G
Osmr
oncostatin M receptor
increases expression
EXP
Cephaloridine results in increased expression of OSMR mRNA
CTD
PMID:18500788
NCBI chr 2:55,907,119...55,961,373
Ensembl chr 2:55,907,132...55,961,262
G
Oxgr1
oxoglutarate receptor 1
increases expression
EXP
Cephaloridine results in increased expression of OXGR1 mRNA
CTD
PMID:18500788
NCBI chr15:97,145,947...97,146,960
Ensembl chr15:97,144,293...97,166,612
G
Padi6
peptidyl arginine deiminase 6
increases expression
EXP
Cephaloridine results in increased expression of PADI6 mRNA
CTD
PMID:18500788
NCBI chr 5:153,021,855...153,037,443
Ensembl chr 5:153,021,965...153,037,414
G
Palb2
partner and localizer of BRCA2
increases expression
EXP
Cephaloridine results in increased expression of PALB2 mRNA
CTD
PMID:18500788
NCBI chr 1:176,665,076...176,689,053
Ensembl chr 1:176,665,076...176,688,990
G
Pask
PAS domain containing serine/threonine kinase
increases expression
EXP
Cephaloridine results in increased expression of PASK mRNA
CTD
PMID:18500788
NCBI chr 9:93,844,275...93,886,036
Ensembl chr 9:93,844,278...93,885,111
G
Pbk
PDZ binding kinase
decreases expression
EXP
Cephaloridine results in decreased expression of PBK mRNA
CTD
PMID:18500788
NCBI chr15:40,022,873...40,034,014
Ensembl chr15:40,023,002...40,034,014
G
Pcdh7
protocadherin 7
decreases expression
EXP
Cephaloridine results in decreased expression of PCDH7 mRNA
CTD
PMID:18500788
NCBI chr14:52,471,801...52,901,696
Ensembl chr14:52,475,610...52,902,051 Ensembl chr14:52,475,610...52,902,051
G
Pcdh9
protocadherin 9
decreases expression
EXP
Cephaloridine results in decreased expression of PCDH9 mRNA
CTD
PMID:18500788
NCBI chr15:69,340,108...70,237,531
Ensembl chr15:69,340,645...70,237,538
G
Pck1
phosphoenolpyruvate carboxykinase 1
decreases expression
EXP
Cephaloridine results in decreased expression of PCK1 mRNA
CTD
PMID:18500788
NCBI chr 3:161,930,256...161,936,205
Ensembl chr 3:161,930,256...161,936,191
G
Pclaf
PCNA clamp associated factor
increases expression
EXP
Cephaloridine results in increased expression of PCLAF mRNA
CTD
PMID:18500788
NCBI chr 8:66,420,606...66,432,994
Ensembl chr 8:66,420,587...66,432,994 Ensembl chr 8:66,420,587...66,432,994
G
Pcna
proliferating cell nuclear antigen
increases expression
EXP
Cephaloridine results in increased expression of PCNA mRNA
CTD
PMID:18500788
NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995
G
Pdia4
protein disulfide isomerase family A, member 4
increases expression
EXP
Cephaloridine results in increased expression of PDIA4 mRNA
CTD
PMID:18172885
NCBI chr 4:76,803,198...76,822,245
Ensembl chr 4:76,803,198...76,822,107
G
Pfn3
profilin 3
decreases expression
EXP
Cephaloridine results in decreased expression of PFN3 mRNA
CTD
PMID:18500788
NCBI chr17:9,217,595...9,218,122
G
Pipox
pipecolic acid and sarcosine oxidase
increases expression
EXP
Cephaloridine results in increased expression of PIPOX mRNA
CTD
PMID:18500788
NCBI chr10:62,769,874...62,783,484
Ensembl chr10:62,769,900...62,782,370
G
Pir
pirin
increases expression
EXP
Cephaloridine results in increased expression of PIR mRNA
CTD
PMID:18500788
NCBI chr X:30,108,536...30,219,269
Ensembl chr X:30,108,538...30,219,218
G
Pkhd1
PKHD1 ciliary IPT domain containing fibrocystin/polyductin
decreases expression
EXP
Cephaloridine results in decreased expression of PKHD1 mRNA
CTD
PMID:18500788
NCBI chr 9:22,547,396...23,037,443
Ensembl chr 9:22,549,513...23,037,381
G
Pkmyt1
protein kinase, membrane associated tyrosine/threonine 1
increases expression
EXP
Cephaloridine results in increased expression of PKMYT1 mRNA
CTD
PMID:18500788
NCBI chr10:12,748,221...12,758,995
Ensembl chr10:12,748,237...12,758,995
G
Pla1a
phospholipase A1 member A
increases expression
EXP
Cephaloridine results in increased expression of PLA1A mRNA
CTD
PMID:18500788
NCBI chr11:62,320,112...62,357,779
Ensembl chr11:62,320,493...62,357,779
G
Plek2
pleckstrin 2
increases expression
EXP
Cephaloridine results in increased expression of PLEK2 mRNA
CTD
PMID:18500788
NCBI chr 6:97,700,123...97,719,417
Ensembl chr 6:97,701,106...97,719,326
G
Plekha5
pleckstrin homology domain containing A5
decreases expression
EXP
Cephaloridine results in decreased expression of PLEKHA5 mRNA
CTD
PMID:18500788
NCBI chr 4:173,333,891...173,503,546
Ensembl chr 4:173,334,055...173,503,546
G
Plk1
polo-like kinase 1
decreases expression
EXP
Cephaloridine results in decreased expression of PLK1 mRNA
CTD
PMID:18500788
NCBI chr 1:176,716,420...176,726,400
Ensembl chr 1:176,716,420...176,726,400
G
Pola2
DNA polymerase alpha 2, accessory subunit
increases expression
EXP
Cephaloridine results in increased expression of POLA2 mRNA
CTD
PMID:18500788
NCBI chr 1:203,227,183...203,251,350
Ensembl chr 1:203,203,388...203,251,348
G
Pold1
DNA polymerase delta 1, catalytic subunit
increases expression
EXP
Cephaloridine results in increased expression of POLD1 mRNA
CTD
PMID:18500788
NCBI chr 1:95,025,462...95,041,559
Ensembl chr 1:95,025,499...95,036,465
G
Pole
DNA polymerase epsilon, catalytic subunit
increases expression
EXP
Cephaloridine results in increased expression of POLE mRNA
CTD
PMID:18500788
NCBI chr12:46,345,420...46,393,984
Ensembl chr12:46,345,420...46,393,939
G
Ppa1
inorganic pyrophosphatase 1
increases expression
EXP
Cephaloridine results in increased expression of PPA1 mRNA
CTD
PMID:18500788
NCBI chr20:29,590,733...29,617,711
Ensembl chr20:29,590,707...29,619,215
G
Ppm1j
protein phosphatase, Mg2+/Mn2+ dependent, 1J
increases expression
EXP
Cephaloridine results in increased expression of PPM1J mRNA
CTD
PMID:18500788
NCBI chr 2:192,278,597...192,283,883
Ensembl chr 2:192,278,517...192,283,882
G
Ppp1r15a
protein phosphatase 1, regulatory subunit 15A
decreases expression
EXP
Cephaloridine results in decreased expression of PPP1R15A mRNA
CTD
PMID:18500788
NCBI chr 1:96,000,053...96,003,128
Ensembl chr 1:96,000,058...96,003,171
G
Prc1
protein regulator of cytokinesis 1
decreases expression
EXP
Cephaloridine results in decreased expression of PRC1 mRNA
CTD
PMID:18500788
NCBI chr 1:134,250,086...134,271,765
Ensembl chr 1:134,250,081...134,271,765
G
Prim1
DNA primase subunit 1
increases expression
EXP
Cephaloridine results in increased expression of PRIM1 mRNA
CTD
PMID:18500788
NCBI chr 7:446,342...462,526
Ensembl chr 7:431,805...462,526
G
Prkar1b
protein kinase cAMP-dependent type I regulatory subunit beta
increases expression
EXP
Cephaloridine results in increased expression of PRKAR1B mRNA
CTD
PMID:18500788
NCBI chr12:15,492,233...15,624,942
Ensembl chr12:15,511,801...15,624,942
G
Prodh2
proline dehydrogenase 2
decreases expression
EXP
Cephaloridine results in decreased expression of PRODH2 mRNA
CTD
PMID:18500788
NCBI chr 1:85,753,558...85,767,165
Ensembl chr 1:85,753,644...85,767,162
G
Prrx1
paired related homeobox 1
decreases expression
EXP
Cephaloridine results in decreased expression of PRRX1 mRNA
CTD
PMID:18500788
NCBI chr13:75,600,777...75,671,896
Ensembl chr13:75,601,706...75,670,866
G
Prss35
serine protease 35
decreases expression
EXP
Cephaloridine results in decreased expression of PRSS35 mRNA
CTD
PMID:18500788
NCBI chr 8:87,714,449...87,731,009
Ensembl chr 8:87,714,966...87,731,009
G
Psmb4
proteasome 20S subunit beta 4
increases expression
EXP
Cephaloridine results in increased expression of PSMB4 mRNA
CTD
PMID:18172885
NCBI chr 2:182,442,757...182,445,532
Ensembl chr 2:182,442,756...182,445,746
G
Ptbp1
polypyrimidine tract binding protein 1
increases expression
EXP
Cephaloridine results in increased expression of PTBP1 mRNA
CTD
PMID:18172885
NCBI chr 7:9,842,574...9,852,332
Ensembl chr 7:9,842,574...9,852,397
G
Ptgr1
prostaglandin reductase 1
increases expression
EXP
Cephaloridine results in increased expression of PTGR1 mRNA
CTD
PMID:18500788
NCBI chr 5:73,784,000...73,802,624
Ensembl chr 5:73,784,009...73,802,666
G
Ptpn11
protein tyrosine phosphatase, non-receptor type 11
decreases expression
EXP
Cephaloridine results in decreased expression of PTPN11 mRNA
CTD
PMID:18500788
NCBI chr12:35,365,436...35,424,925
Ensembl chr12:35,383,144...35,424,925
G
Ptprb
protein tyrosine phosphatase, receptor type, B
decreases expression
EXP
Cephaloridine results in decreased expression of PTPRB mRNA
CTD
PMID:18500788
NCBI chr 7:51,953,375...52,034,751
Ensembl chr 7:51,930,015...52,034,748
G
Ptprn2
protein tyrosine phosphatase, receptor type N2
increases expression
EXP
Cephaloridine results in increased expression of PTPRN2 mRNA
CTD
PMID:18500788
NCBI chr 6:137,439,572...138,191,575
Ensembl chr 6:137,439,540...138,191,575
G
Ptrh1
peptidyl-tRNA hydrolase 1 homolog
increases expression
EXP
Cephaloridine results in increased expression of PTRH1 mRNA
CTD
PMID:18500788
NCBI chr 3:16,064,867...16,071,098
Ensembl chr 3:16,064,880...16,070,648
G
Pvr
PVR cell adhesion molecule
increases expression
EXP
Cephaloridine results in increased expression of PVR mRNA
CTD
PMID:18500788
NCBI chr 1:79,561,294...79,576,700
Ensembl chr 1:79,546,879...79,576,715
G
Rab11fip3
RAB11 family interacting protein 3
decreases expression
EXP
Cephaloridine results in decreased expression of RAB11FIP3 mRNA
CTD
PMID:18500788
NCBI chr10:15,002,650...15,086,382
Ensembl chr10:15,002,926...15,118,479
G
Rab31
RAB31, member RAS oncogene family
decreases expression
EXP
Cephaloridine results in decreased expression of RAB31 mRNA
CTD
PMID:18500788
NCBI chr 9:105,246,712...105,382,973
Ensembl chr 9:105,246,709...105,381,253
G
Rad18
RAD18 E3 ubiquitin protein ligase
increases expression
EXP
Cephaloridine results in increased expression of RAD18 mRNA
CTD
PMID:18500788
NCBI chr 4:145,735,654...145,821,102
Ensembl chr 4:145,735,654...145,821,069
G
Rb1
RB transcriptional corepressor 1
affects activity
EXP
Cephaloridine affects the activity of RB1 protein
CTD
PMID:18500788
NCBI chr15:48,371,295...48,502,473
Ensembl chr15:48,371,296...48,502,302
G
Rbp2
retinol binding protein 2
increases expression
EXP
Cephaloridine results in increased expression of RBP2 mRNA
CTD
PMID:18500788
NCBI chr 8:99,079,293...99,104,489
Ensembl chr 8:99,079,104...99,104,473
G
Rbsn
rabenosyn, RAB effector
decreases expression
EXP
Cephaloridine results in decreased expression of RBSN mRNA
CTD
PMID:18500788
NCBI chr 4:124,682,228...124,712,578
Ensembl chr 4:124,683,969...124,712,578
G
Rdh16
retinol dehydrogenase 16
decreases expression
EXP
Cephaloridine results in decreased expression of RDH2 mRNA
CTD
PMID:18500788
NCBI chr 7:63,616,711...63,625,053
Ensembl chr 7:63,597,536...63,624,124
G
Recql4
RecQ like helicase 4
increases expression
EXP
Cephaloridine results in increased expression of RECQL4 mRNA
CTD
PMID:18500788
NCBI chr 7:108,423,453...108,430,790
Ensembl chr 7:108,423,455...108,430,619
G
Rela
RELA proto-oncogene, NF-kB subunit
affects activity
EXP
Cephaloridine affects the activity of RELA protein
CTD
PMID:18500788
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
G
Rfc3
replication factor C subunit 3
increases expression
EXP
Cephaloridine results in increased expression of RFC3 mRNA
CTD
PMID:18500788
NCBI chr12:1,000,987...1,011,778
Ensembl chr12:1,000,994...1,011,778
G
Rfc4
replication factor C subunit 4
increases expression
EXP
Cephaloridine results in increased expression of RFC4 mRNA
CTD
PMID:18500788
NCBI chr11:77,749,642...77,764,123
Ensembl chr11:77,749,638...77,764,122
G
Rgn
regucalcin
decreases expression
EXP
Cephaloridine results in decreased expression of RGN mRNA
CTD
PMID:8584014 PMID:18500788
NCBI chr X:1,619,030...1,634,456
Ensembl chr X:1,619,032...1,634,450
G
Rgs11
regulator of G-protein signaling 11
increases expression
EXP
Cephaloridine results in increased expression of RGS11 mRNA
CTD
PMID:18500788
NCBI chr10:15,222,804...15,231,062
Ensembl chr10:15,222,803...15,231,060
G
Rhcg
Rh family, C glycoprotein
increases expression
EXP
Cephaloridine results in increased expression of RHCG mRNA
CTD
PMID:18500788
NCBI chr 1:133,531,704...133,555,902
Ensembl chr 1:133,531,716...133,555,876
G
Rhobtb1
Rho-related BTB domain containing 1
decreases expression
EXP
Cephaloridine results in decreased expression of RHOBTB1 mRNA
CTD
PMID:18500788
NCBI chr20:19,327,142...19,456,121
Ensembl chr20:19,327,155...19,403,012
G
Rhpn2
rhophilin, Rho GTPase binding protein 2
increases expression
EXP
Cephaloridine results in increased expression of RHPN2 mRNA
CTD
PMID:18500788
NCBI chr 1:87,991,143...88,051,895
Ensembl chr 1:87,991,144...88,051,902
G
Rida
reactive intermediate imine deaminase A homolog
decreases expression
EXP
Cephaloridine results in decreased expression of RIDA mRNA
CTD
PMID:18500788
NCBI chr 7:65,691,429...65,705,257
Ensembl chr 7:65,691,435...65,705,716
G
Rnd1
Rho family GTPase 1
increases expression
EXP
Cephaloridine results in increased expression of RND1 mRNA
CTD
PMID:18500788
NCBI chr 7:129,821,311...129,828,385
Ensembl chr 7:129,821,311...129,828,399
G
Rnf227
ring finger protein 227
increases expression
EXP
Cephaloridine results in increased expression of RNF227 mRNA
CTD
PMID:18500788
NCBI chr10:54,061,054...54,063,015
Ensembl chr10:54,059,947...54,063,010
G
Rpl23a
ribosomal protein L23A
increases expression
EXP
Cephaloridine results in increased expression of RPL23A mRNA
CTD
PMID:18500788
NCBI chr10:63,076,660...63,079,346
Ensembl chr10:63,076,066...63,079,346 Ensembl chr15:63,076,066...63,079,346
G
Rpl23al1
ribosomal protein L23A like 1
increases expression
EXP
Cephaloridine results in increased expression of RPL23AL1 mRNA
CTD
PMID:18500788
NCBI chr 2:38,452,814...38,453,384
Ensembl chr 2:38,451,401...38,453,417
G
Rpl32l4
ribosomal protein L32 like 4
decreases expression
EXP
Cephaloridine results in decreased expression of RPL32L4 mRNA
CTD
PMID:18500788
NCBI chr 8:84,691,128...84,692,042
G
Rrm2
ribonucleotide reductase regulatory subunit M2
decreases expression
EXP
Cephaloridine results in decreased expression of RRM2 mRNA
CTD
PMID:18500788
NCBI chr 6:41,339,858...41,346,774
Ensembl chr 6:41,340,557...41,346,773
G
Runx1t1
RUNX1 partner transcriptional co-repressor 1
decreases expression
EXP
Cephaloridine results in decreased expression of RUNX1T1 mRNA
CTD
PMID:18500788
NCBI chr 5:27,187,674...27,338,070
Ensembl chr 5:27,187,551...27,335,592
G
Rxrg
retinoid X receptor gamma
increases expression
EXP
Cephaloridine results in increased expression of RXRG mRNA
CTD
PMID:18500788
NCBI chr13:79,743,430...79,785,173
Ensembl chr13:79,743,563...79,785,167
G
Scgb3a1
secretoglobin, family 3A, member 1
increases expression
EXP
Cephaloridine results in increased expression of SCGB3A1 mRNA
CTD
PMID:18500788
NCBI chr10:33,968,059...33,969,366
Ensembl chr10:33,968,059...33,969,476
G
Scgb3a2
secretoglobin, family 3A, member 2
increases expression
EXP
Cephaloridine results in increased expression of SCGB3A2 mRNA
CTD
PMID:18500788
NCBI chr18:35,932,840...35,935,762
Ensembl chr18:35,932,840...35,935,762
G
Sct
secretin
increases expression
EXP
Cephaloridine results in increased expression of SCT mRNA
CTD
PMID:18500788
NCBI chr 1:196,382,857...196,383,668
Ensembl chr 1:196,382,856...196,383,658
G
Sectm1b
secreted and transmembrane 1B
increases expression
EXP
Cephaloridine results in increased expression of SECTM1A mRNA
CTD
PMID:18500788
NCBI chr10:106,324,070...106,333,779
Ensembl chr10:106,325,203...106,333,769
G
Selenop
selenoprotein P
decreases expression
EXP
Cephaloridine results in decreased expression of SELENOP mRNA
CTD
PMID:18500788
NCBI chr 2:52,498,123...52,508,409
Ensembl chr 2:52,498,339...52,508,852
G
Sema4c
semaphorin 4C
decreases expression
EXP
Cephaloridine results in decreased expression of SEMA4C mRNA
CTD
PMID:18500788
NCBI chr 9:38,791,668...38,802,171
Ensembl chr 9:38,791,670...38,802,128
G
Septin10
septin 10
decreases expression
EXP
Cephaloridine results in decreased expression of SEPTIN10 mRNA
CTD
PMID:18500788
NCBI chr20:27,101,764...27,194,997
Ensembl chr20:27,101,752...27,194,780
G
Sh2b2
SH2B adaptor protein 2
increases expression
EXP
Cephaloridine results in increased expression of SH2B2 mRNA
CTD
PMID:18500788
NCBI chr12:20,427,057...20,456,845
Ensembl chr12:20,429,043...20,456,844
G
Sh3bp2
SH3-domain binding protein 2
increases expression
EXP
Cephaloridine results in increased expression of SH3BP2 mRNA
CTD
PMID:18500788
NCBI chr14:76,176,097...76,213,300
Ensembl chr14:76,176,101...76,213,251
G
Shroom4
shroom family member 4
decreases expression
EXP
Cephaloridine results in decreased expression of SHROOM4 mRNA
CTD
PMID:18500788
NCBI chr X:15,869,065...16,076,850
Ensembl chr X:15,869,065...16,076,869
G
Ska1
spindle and kinetochore associated complex subunit 1
decreases expression
EXP
Cephaloridine results in decreased expression of SKA1 mRNA
CTD
PMID:18500788
NCBI chr18:67,794,722...67,805,037
Ensembl chr18:67,794,725...67,805,037
G
Slc15a3
solute carrier family 15 member 3
increases expression
EXP
Cephaloridine results in increased expression of SLC15A3 mRNA
CTD
PMID:18500788
NCBI chr 1:207,492,365...207,507,158
Ensembl chr 1:207,492,365...207,507,157
G
Slc16a12
solute carrier family 16, member 12
decreases expression
EXP
Cephaloridine results in decreased expression of SLC16A12 mRNA
CTD
PMID:18500788
NCBI chr 1:232,184,004...232,262,170
Ensembl chr 1:232,185,907...232,262,141
G
Slc16a14
solute carrier family 16, member 14
decreases expression
EXP
Cephaloridine results in decreased expression of SLC16A14 mRNA
CTD
PMID:18500788
NCBI chr 9:86,110,066...86,137,546
Ensembl chr 9:86,112,894...86,137,318
G
Slc1a5
solute carrier family 1 member 5
increases expression
EXP
Cephaloridine results in increased expression of SLC1A5 mRNA
CTD
PMID:18500788
NCBI chr 1:77,456,849...77,470,952
Ensembl chr 1:77,456,694...77,470,952
G
Slc22a23
solute carrier family 22, member 23
decreases expression
EXP
Cephaloridine results in decreased expression of SLC22A23 mRNA
CTD
PMID:18500788
NCBI chr17:30,544,106...30,709,790
Ensembl chr17:30,544,106...30,709,790
G
Slc22a5
solute carrier family 22 member 5
decreases expression
EXP
Cephaloridine results in decreased expression of SLC22A5 mRNA
CTD
PMID:18500788
NCBI chr10:38,008,303...38,035,474
Ensembl chr10:38,008,311...38,035,309
G
Slc22a6
solute carrier family 22 member 6
increases import increases uptake multiple interactions
EXP ISO
SLC22A6 protein results in increased import of Cephaloridine SLC22A6 protein results in increased uptake of Cephaloridine Cephaloridine inhibits the reaction [SLC22A6 protein results in increased uptake of p-Aminohippuric Acid]
CTD
PMID:10594788 PMID:16098483
NCBI chr 1:205,522,579...205,531,179
Ensembl chr 1:205,522,729...205,531,173
G
Slc22a8
solute carrier family 22 member 8
increases uptake multiple interactions
ISO
SLC22A8 protein results in increased uptake of Cephaloridine Cephaloridine inhibits the reaction [SLC22A8 protein results in increased uptake of estrone sulfate]
CTD
PMID:16098483
NCBI chr 1:205,496,331...205,516,378
Ensembl chr 1:205,498,084...205,517,450
G
Slc35d2
solute carrier family 35 member D2
increases expression
EXP
Cephaloridine results in increased expression of SLC35D2 mRNA
CTD
PMID:18500788
NCBI chr17:987,899...1,019,747
Ensembl chr17:988,157...1,019,743
G
Slc39a4
solute carrier family 39 member 4
increases expression
EXP
Cephaloridine results in increased expression of SLC39A4 mRNA
CTD
PMID:18500788
NCBI chr 7:108,333,368...108,337,553
Ensembl chr 7:108,333,381...108,337,553
G
Slc41a2
solute carrier family 41 member 2
increases expression
EXP
Cephaloridine results in increased expression of SLC41A2 mRNA
CTD
PMID:18500788
NCBI chr 7:20,383,714...20,491,178
Ensembl chr 7:20,383,757...20,491,166
G
Slc46a3
solute carrier family 46, member 3
increases expression
EXP
Cephaloridine results in increased expression of SLC46A3 mRNA
CTD
PMID:18500788
NCBI chr12:7,140,610...7,157,093
Ensembl chr12:7,140,668...7,157,092
G
Slc4a4
solute carrier family 4 member 4
decreases expression
EXP
Cephaloridine results in decreased expression of SLC4A4 mRNA
CTD
PMID:18500788
NCBI chr14:18,841,289...19,293,297
Ensembl chr14:18,845,159...19,272,883
G
Slc5a3
solute carrier family 5 member 3
increases expression
EXP
Cephaloridine results in increased expression of SLC5A3 mRNA
CTD
PMID:18500788
NCBI chr11:31,313,847...31,316,293
Ensembl chr11:31,295,476...31,318,883
G
Slc7a10
solute carrier family 7 member 10
increases expression
EXP
Cephaloridine results in increased expression of SLC7A10 mRNA
CTD
PMID:18500788
NCBI chr 1:87,829,084...87,845,073
Ensembl chr 1:87,829,175...87,845,071
G
Slc7a5
solute carrier family 7 member 5
increases expression
EXP
Cephaloridine results in increased expression of SLC7A5 mRNA
CTD
PMID:18500788
NCBI chr19:49,935,220...49,963,823
Ensembl chr19:49,935,220...49,963,823
G
Slc7a7
solute carrier family 7 member 7
decreases expression
EXP
Cephaloridine results in decreased expression of SLC7A7 mRNA
CTD
PMID:18500788
NCBI chr15:27,822,088...27,873,121
Ensembl chr15:27,822,091...27,865,648
G
Slc8a1
solute carrier family 8 member A1
decreases expression
EXP
Cephaloridine results in decreased expression of SLC8A1 mRNA
CTD
PMID:18500788
NCBI chr 6:13,194,609...13,547,369
Ensembl chr 6:13,194,662...13,535,628
G
Slpi
secretory leukocyte peptidase inhibitor
increases expression
EXP
Cephaloridine results in increased expression of SLPI mRNA
CTD
PMID:18500788
NCBI chr 3:153,082,208...153,084,457
Ensembl chr 3:153,082,369...153,084,453
G
Smyd1
SET and MYND domain containing 1
increases expression
EXP
Cephaloridine results in increased expression of SMYD1 mRNA
CTD
PMID:18500788
NCBI chr 4:103,195,330...103,252,989
Ensembl chr 4:103,200,322...103,311,766
G
Snapc2
small nuclear RNA activating complex, polypeptide 2
increases expression
EXP
Cephaloridine results in increased expression of SNAPC2 mRNA
CTD
PMID:18500788
NCBI chr12:2,605,794...2,608,997
Ensembl chr12:2,605,810...2,608,999
G
Socs3
suppressor of cytokine signaling 3
decreases expression
EXP
Cephaloridine results in decreased expression of SOCS3 mRNA
CTD
PMID:18500788
NCBI chr10:103,193,909...103,197,322
Ensembl chr10:103,193,537...103,197,787
G
Spetex2b
Spetex-2B protein
increases expression
EXP
Cephaloridine results in increased expression of SPETEX2B mRNA
CTD
PMID:18500788
G
Spetex2d
Spetex-2D protein
increases expression
EXP
Cephaloridine results in increased expression of SPETEX2D mRNA
CTD
PMID:18500788
G
Sphk1
sphingosine kinase 1
increases expression
EXP
Cephaloridine results in increased expression of SPHK1 mRNA
CTD
PMID:18500788
NCBI chr10:101,758,567...101,764,240
Ensembl chr10:101,758,711...101,764,240
G
Spink1
serine peptidase inhibitor, Kazal type 1
decreases expression
EXP
Cephaloridine results in decreased expression of SPINK1 mRNA
CTD
PMID:18500788
NCBI chr18:35,870,723...35,882,693
Ensembl chr18:35,824,550...35,882,642
G
Srpra
SRP receptor subunit alpha
decreases expression
EXP
Cephaloridine results in decreased expression of SRPRA mRNA
CTD
PMID:18500788
NCBI chr 8:33,560,365...33,566,458
Ensembl chr 8:33,560,348...33,566,470
G
Stat3
signal transducer and activator of transcription 3
increases expression
EXP
Cephaloridine results in increased expression of STAT3 mRNA
CTD
PMID:18500788
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
G
Stk35
serine/threonine kinase 35
increases expression
EXP
Cephaloridine results in increased expression of STK35 mRNA
CTD
PMID:18500788
NCBI chr 3:117,016,819...117,049,131
Ensembl chr 3:117,016,950...117,048,066
G
Stra6
signaling receptor and transporter of retinol STRA6
decreases expression
EXP
Cephaloridine results in decreased expression of STRA6 mRNA
CTD
PMID:18500788
NCBI chr 8:58,548,899...58,568,861
Ensembl chr 8:58,549,736...58,568,860
G
Sult1c2a
sulfotransferase family 1C member 2A
decreases expression
EXP
Cephaloridine results in decreased expression of SULT1C2 mRNA; Cephaloridine results in decreased expression of SULT1C2A mRNA
CTD
PMID:18500788
NCBI chr 9:6,873,697...6,904,736
Ensembl chr 9:6,874,249...6,904,734
G
Sult4a1
sulfotransferase family 4A, member 1
increases expression
EXP
Cephaloridine results in increased expression of SULT4A1 mRNA
CTD
PMID:18500788
NCBI chr 7:115,216,066...115,240,156
Ensembl chr 7:115,216,066...115,240,085
G
Surf6
surfeit 6
decreases expression
EXP
Cephaloridine results in decreased expression of SURF6 mRNA
CTD
PMID:18500788
NCBI chr 3:10,221,450...10,232,306
Ensembl chr 3:10,221,452...10,232,251
G
Susd2
sushi domain containing 2
decreases expression
EXP
Cephaloridine results in decreased expression of SUSD2 mRNA
CTD
PMID:18500788
NCBI chr20:13,017,516...13,024,820
Ensembl chr20:13,017,477...13,024,903
G
Syne1
spectrin repeat containing nuclear envelope protein 1
decreases expression
EXP
Cephaloridine results in decreased expression of SYNE1 mRNA
CTD
PMID:18500788
NCBI chr 1:41,512,146...41,983,382
Ensembl chr 1:41,512,030...41,983,322
G
Syne2
spectrin repeat containing nuclear envelope protein 2
decreases expression
EXP
Cephaloridine results in decreased expression of SYNE2 mRNA
CTD
PMID:18500788
NCBI chr 6:94,537,088...94,848,085
Ensembl chr 6:94,537,088...94,848,064
G
Sytl5
synaptotagmin-like 5
increases expression
EXP
Cephaloridine results in increased expression of SYTL5 mRNA
CTD
PMID:18500788
NCBI chr X:12,775,529...13,030,134
Ensembl chr X:12,788,698...13,030,175
G
Tac3
tachykinin precursor 3
increases expression
EXP
Cephaloridine results in increased expression of TAC2 mRNA
CTD
PMID:18500788
NCBI chr 7:63,562,552...63,569,170
Ensembl chr 7:63,562,552...63,569,170
G
Tbx3
T-box transcription factor 3
decreases expression
EXP
Cephaloridine results in decreased expression of TBX3 mRNA
CTD
PMID:18500788
NCBI chr12:36,879,924...36,894,849
Ensembl chr12:36,881,445...36,893,708
G
Tcf12
transcription factor 12
decreases expression
EXP
Cephaloridine results in decreased expression of TCF12 mRNA
CTD
PMID:18500788
NCBI chr 8:72,490,447...72,799,265
Ensembl chr 8:72,492,567...72,799,201
G
Tcf19
transcription factor 19
increases expression
EXP
Cephaloridine results in increased expression of TCF19 mRNA
CTD
PMID:18500788
NCBI chr20:3,218,756...3,222,861
Ensembl chr20:3,218,693...3,223,271
G
Tfrc
transferrin receptor
increases expression
EXP
Cephaloridine results in increased expression of TFRC mRNA
CTD
PMID:18500788
NCBI chr11:68,163,413...68,185,257
Ensembl chr11:68,163,413...68,185,257
G
Ticrr
TOPBP1-interacting checkpoint and replication regulator
increases expression
EXP
Cephaloridine results in increased expression of TICRR mRNA
CTD
PMID:18500788
NCBI chr 1:133,597,618...133,639,513
Ensembl chr 1:133,597,716...133,639,523
G
Timeless
timeless circadian regulator
increases expression
EXP
Cephaloridine results in increased expression of TIMELESS mRNA
CTD
PMID:18500788
NCBI chr 7:654,804...678,769
Ensembl chr 7:654,822...678,738
G
Timp1
TIMP metallopeptidase inhibitor 1
increases expression
EXP
Cephaloridine results in increased expression of TIMP1 mRNA
CTD
PMID:18500788
NCBI chr X:1,212,969...1,217,714
Ensembl chr X:1,212,972...1,217,664
G
Tlr2
toll-like receptor 2
increases expression
EXP
Cephaloridine results in increased expression of TLR2 mRNA
CTD
PMID:18500788
NCBI chr 2:169,200,620...169,206,819
Ensembl chr 2:169,197,419...169,206,630
G
Tmem163
transmembrane protein 163
increases expression
EXP
Cephaloridine results in increased expression of TMEM163 mRNA
CTD
PMID:18500788
NCBI chr13:38,967,913...39,141,664
Ensembl chr13:38,968,101...39,141,452
G
Tmem252
transmembrane protein 252
decreases expression
EXP
Cephaloridine results in decreased expression of TMEM252 mRNA
CTD
PMID:18500788
NCBI chr 1:222,316,982...222,321,946
Ensembl chr 1:222,316,795...222,321,943
G
Tmem270
transmembrane protein 270
increases expression
EXP
Cephaloridine results in increased expression of TMEM270 mRNA
CTD
PMID:18500788
NCBI chr12:21,793,631...21,798,723
Ensembl chr12:21,794,130...21,798,731
G
Tmem63c
transmembrane protein 63c
increases expression
EXP
Cephaloridine results in increased expression of TMEM63C mRNA
CTD
PMID:18500788
NCBI chr 6:106,667,389...106,738,778
Ensembl chr 6:106,672,934...106,736,990
G
Tmem86a
transmembrane protein 86A
decreases expression
EXP
Cephaloridine results in decreased expression of TMEM86A mRNA
CTD
PMID:18500788
NCBI chr 1:97,595,910...97,600,260
Ensembl chr 1:97,595,842...97,600,260
G
Tnfrsf12a
TNF receptor superfamily member 12A
increases expression
EXP
Cephaloridine results in increased expression of TNFRSF12A mRNA
CTD
PMID:18500788
NCBI chr10:12,707,077...12,709,071
Ensembl chr10:12,689,890...12,709,045
G
Tnfrsf1a
TNF receptor superfamily member 1A
increases expression
EXP
Cephaloridine results in increased expression of TNFRSF1A mRNA
CTD
PMID:18500788
NCBI chr 4:158,150,815...158,163,592
Ensembl chr 4:158,150,820...158,163,591
G
Tns1
tensin 1
decreases expression
EXP
Cephaloridine results in decreased expression of TNS1 mRNA
CTD
PMID:18500788
NCBI chr 9:75,491,886...75,702,853
Ensembl chr 9:75,495,814...75,703,225
G
Tns4
tensin 4
increases expression
EXP
Cephaloridine results in increased expression of TNS4 mRNA
CTD
PMID:18500788
NCBI chr10:84,021,965...84,041,346
Ensembl chr10:84,021,966...84,041,346
G
Tonsl
tonsoku-like, DNA repair protein
increases expression
EXP
Cephaloridine results in increased expression of TONSL mRNA
CTD
PMID:18500788
NCBI chr 7:108,345,704...108,360,792
Ensembl chr 7:108,346,047...108,360,750
G
Top2a
DNA topoisomerase II alpha
decreases expression
EXP
Cephaloridine results in decreased expression of TOP2A mRNA
CTD
PMID:18500788
NCBI chr10:83,945,731...83,976,874
Ensembl chr10:83,945,735...83,976,874
G
Tph1
tryptophan hydroxylase 1
increases expression
EXP
Cephaloridine results in increased expression of TPH1 mRNA
CTD
PMID:18500788
NCBI chr 1:97,157,375...97,178,415
Ensembl chr 1:97,157,409...97,178,344
G
Trib3
tribbles pseudokinase 3
increases expression
EXP
Cephaloridine results in increased expression of TRIB3 mRNA
CTD
PMID:18500788
NCBI chr 3:140,809,634...140,815,230
Ensembl chr 3:140,809,043...140,814,497
G
Tril
TLR4 interactor with leucine-rich repeats
decreases expression
EXP
Cephaloridine results in decreased expression of TRIL mRNA
CTD
PMID:18500788
NCBI chr 4:82,922,327...82,927,172
Ensembl chr 4:82,922,328...82,927,172
G
Trpc6
transient receptor potential cation channel, subfamily C, member 6
increases expression
EXP
Cephaloridine results in increased expression of TRPC6 mRNA
CTD
PMID:18500788
NCBI chr 8:5,759,387...5,864,000
Ensembl chr 8:5,758,935...5,828,092
G
Ttc39a
tetratricopeptide repeat domain 39A
increases expression
EXP
Cephaloridine results in increased expression of TTC39A mRNA
CTD
PMID:18500788
NCBI chr 5:124,165,102...124,204,740
Ensembl chr 5:124,151,760...124,204,973
G
Ttk
Ttk protein kinase
decreases expression
EXP
Cephaloridine results in decreased expression of TTK mRNA
CTD
PMID:18500788
NCBI chr 8:84,754,329...84,792,653
Ensembl chr 8:84,754,315...84,792,651
G
Ttll2
tubulin tyrosine ligase like 2
increases expression
EXP
Cephaloridine results in increased expression of TTLL2 mRNA
CTD
PMID:18500788
NCBI chr 1:52,967,183...52,976,690
Ensembl chr 1:52,968,408...52,976,697
G
Tubb3
tubulin, beta 3 class III
increases expression
EXP
Cephaloridine results in increased expression of TUBB3 mRNA
CTD
PMID:18500788
NCBI chr19:51,457,187...51,466,243
Ensembl chr19:51,457,184...51,466,243
G
Tubb6
tubulin, beta 6 class V
increases expression
EXP
Cephaloridine results in increased expression of TUBB6 mRNA
CTD
PMID:18500788
NCBI chr18:60,943,394...60,953,031
Ensembl chr18:60,943,375...60,954,418
G
Tyms
thymidylate synthetase
increases expression
EXP
Cephaloridine results in increased expression of TYMS mRNA
CTD
PMID:18500788
NCBI chr 9:113,313,454...113,329,551
Ensembl chr 9:113,313,452...113,329,536
G
Ubd
ubiquitin D
increases expression
EXP
Cephaloridine results in increased expression of UBD mRNA
CTD
PMID:18500788
NCBI chr20:1,385,487...1,387,438
Ensembl chr20:1,385,864...1,408,639 Ensembl chr20:1,385,864...1,408,639
G
Ube2c
ubiquitin-conjugating enzyme E2C
decreases expression
EXP
Cephaloridine results in decreased expression of UBE2C mRNA
CTD
PMID:18500788
NCBI chr 3:153,506,636...153,509,036
Ensembl chr 3:153,506,636...153,513,339
G
Ube2l6
ubiquitin-conjugating enzyme E2L 6
increases expression
EXP
Cephaloridine results in increased expression of UBE2L6 mRNA
CTD
PMID:18500788
NCBI chr 3:69,873,025...69,888,042
Ensembl chr 3:69,873,424...69,888,048
G
Ubl7
ubiquitin-like 7
increases expression
EXP
Cephaloridine results in increased expression of UBL7 mRNA
CTD
PMID:18500788
NCBI chr 8:58,321,279...58,340,353
Ensembl chr 8:58,320,866...58,340,344
G
Uchl1
ubiquitin C-terminal hydrolase L1
increases expression
EXP
Cephaloridine results in increased expression of UCHL1 mRNA
CTD
PMID:18500788
NCBI chr14:41,485,031...41,495,590
Ensembl chr14:41,485,031...41,495,590
G
Ugt1a2
UDP glucuronosyltransferase 1 family, polypeptide A2
increases expression
EXP
Cephaloridine results in increased expression of UGT1A2 mRNA
CTD
PMID:18500788
NCBI chr 9:88,791,216...88,808,465
Ensembl chr 9:88,713,184...88,808,465
G
Ugt1a6
UDP glucuronosyltransferase family 1 member A6
increases expression
EXP
Cephaloridine results in increased expression of UGT1A6 mRNA
CTD
PMID:18500788
NCBI chr 9:88,747,213...88,808,465
Ensembl chr 9:88,713,184...88,808,465
G
Ugt2b7
UDP glucuronosyltransferase family 2 member B7
increases expression
EXP
Cephaloridine results in increased expression of UGT2B7 mRNA
CTD
PMID:18500788
NCBI chr14:20,896,682...20,919,604
Ensembl chr14:20,896,682...20,919,604
G
Uhmk1
U2AF homology motif kinase 1
increases expression
EXP
Cephaloridine results in increased expression of UHMK1 mRNA
CTD
PMID:18500788
NCBI chr13:82,396,646...82,416,292
Ensembl chr13:82,401,187...82,416,292
G
Uhmk1l1
U2AF homology motif kinase 1l1
increases expression
EXP
Cephaloridine results in increased expression of UHMK1L1 mRNA
CTD
PMID:18500788
NCBI chr17:42,241,640...42,243,666
G
Upp1
uridine phosphorylase 1
increases expression
EXP
Cephaloridine results in increased expression of UPP1 mRNA
CTD
PMID:18500788
NCBI chr14:83,809,495...83,829,299
Ensembl chr14:83,809,960...83,829,462
G
Usp24
ubiquitin specific peptidase 24
decreases expression
EXP
Cephaloridine results in decreased expression of USP24 mRNA
CTD
PMID:18500788
NCBI chr 5:121,080,687...121,210,321
Ensembl chr 5:121,080,470...121,210,311
G
Vcam1
vascular cell adhesion molecule 1
increases expression
EXP
Cephaloridine results in increased expression of VCAM1 mRNA
CTD
PMID:18500788
NCBI chr 2:204,038,120...204,057,852
Ensembl chr 2:204,038,114...204,057,958
G
Vpreb3
V-set pre-B cell surrogate light chain 3
increases expression
EXP
Cephaloridine results in increased expression of VPREB3 mRNA
CTD
PMID:18500788
NCBI chr20:12,717,421...12,718,785
Ensembl chr20:12,716,779...12,719,520
G
Wdhd1
WD repeat and HMG-box DNA binding protein 1
increases expression
EXP
Cephaloridine results in increased expression of WDHD1 mRNA
CTD
PMID:18500788
NCBI chr15:20,478,310...20,523,106
Ensembl chr15:20,489,291...20,523,096
G
Zc3h13
zinc finger CCCH type containing 13
decreases expression
EXP
Cephaloridine results in decreased expression of ZC3H13 mRNA
CTD
PMID:18500788
NCBI chr15:50,607,335...50,671,802
Ensembl chr15:50,607,380...50,671,802
G
Zdhhc18
zinc finger DHHC-type palmitoyltransferase 18
decreases expression
EXP
Cephaloridine results in decreased expression of ZDHHC18 mRNA
CTD
PMID:18500788
NCBI chr 5:145,821,534...145,859,989
Ensembl chr 5:145,831,446...145,859,993
G
Zfand2a
zinc finger AN1-type containing 2A
decreases expression
EXP
Cephaloridine results in decreased expression of ZFAND2A mRNA
CTD
PMID:18500788
NCBI chr12:15,161,601...15,172,679
Ensembl chr12:15,161,639...15,172,677
G
Zfp367
zinc finger protein 367
increases expression
EXP
Cephaloridine results in increased expression of ZFP367 mRNA
CTD
PMID:18500788
NCBI chr17:965,161...984,290
Ensembl chr17:965,161...984,287
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all